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Abstract
Natural killer (NK) cells play critical roles in host defense against tumors and intracellular pathogens. Various
transcription factors have been reported to alter NK cell development, but the definitive transcriptional
program governing this process is not well understood. Our laboratory has shown previously that the T-box
transcription factors T-bet and Eomesodermin (Eomes) direct fate and function in cytotoxic T lymphocytes.
We thus endeavored to define the roles of T-bet and Eomes in the differentiation of NK cells. We find that NK
progenitor cells give rise to immature-phenotype NK cells, which express the death ligand TRAIL and the
transcription factor T-bet but lack a combinatorial repertoire of activating and inhibitory Ly49 molecules,
responsible for the broad specificity of NK cells against microbial components and missing self. T-bet appears
essential to stabilize this immature lineage. Immature NK cells give rise to mature NK cells that express the
integrin CD49b (DX5+) and a diverse repertoire of Ly49 family receptors. Mature NK cells maintain
expression of T-bet and induce expression of Eomes. T-bet is dispensable for the development of mature NK
cells. Eomes, however, is critical for the development of mature NK cells. Eomes also maintains aspects of the
mature phenotype. The effects of T-bet deletion and Eomes deletion are complementary and additive, as no
NK cells are observed in mice lacking both T-bet and Eomes. The biological basis for stepwise maturation of
NK cells appears to rest in a strict prohibition against induction of Eomes until post-natal life. Restriction of
Eomes expression by fetal and adult liver limits NK development to a T-bet-dependent, immature state,
whereas medullary hematopoiesis is permissive for Eomes induction and progression to NK cell maturity.
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DEVELOPMENT OF NATURAL KILLER CELLS 
REGULATED BY T-BOX TRANSCRIPTION FACTORS 
 
Scott Michael Gordon 
Steven L. Reiner 
 
Natural killer (NK) cells play critical roles in host defense against tumors and 
intracellular pathogens.  Various transcription factors have been reported to alter 
NK cell development, but the definitive transcriptional program governing this 
process is not well understood.  Our laboratory has shown previously that the T-
box transcription factors T-bet and Eomesodermin (Eomes) direct fate and 
function in cytotoxic T lymphocytes.  We thus endeavored to define the roles of 
T-bet and Eomes in the differentiation of NK cells. We find that NK progenitor 
cells give rise to immature-phenotype NK cells, which express the death ligand 
TRAIL and the transcription factor T-bet but lack a combinatorial repertoire of 
activating and inhibitory Ly49 molecules, responsible for the broad specificity of 
NK cells against microbial components and missing self.  T-bet appears essential 
to stabilize this immature lineage.  Immature NK cells give rise to mature NK cells 
that express the integrin CD49b (DX5+) and a diverse repertoire of Ly49 family 
receptors.  Mature NK cells maintain expression of T-bet and induce expression 
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of Eomes.  T-bet is dispensable for the development of mature NK cells.  Eomes, 
however, is critical for the development of mature NK cells.  Eomes also 
maintains aspects of the mature phenotype.  The effects of T-bet deletion and 
Eomes deletion are complementary and additive, as no NK cells are observed in 
mice lacking both T-bet and Eomes.  The biological basis for stepwise maturation 
of NK cells appears to rest in a strict prohibition against induction of Eomes until 
post-natal life.  Restriction of Eomes expression by fetal and adult liver limits NK 
development to a T-bet-dependent, immature state, whereas medullary 
hematopoiesis is permissive for Eomes induction and progression to NK cell 
maturity.  These findings reveal critical, genetically separable checkpoints in 
maturation of NK cells.  
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Function of Natural Killer Cells 
Natural Killer (NK) cells were first identified as lymphocytes with natural reactivity 
to tumor cell lines in vitro (Kiessling et al., 1975a; 1975b).  Able to enact rapid, 
contact-dependent cytolysis without prior exposure to target cells, NK cells were 
immediately distinguished from CD8+ cytotoxic T lymphocytes.  Additionally, NK 
cells developed in the absence of the thymus, a primary lymphoid organ required 
for T cell development.  T and B lymphocytes, which comprise the adaptive 
immune system, rearrange the antigen receptor locus in a random fashion to 
achieve fine antigen specificity.  In contrast, NK cells came to be defined as 
innate lymphocytes that rely on germline-encoded, non-rearranged receptors to 
detect targets and to activate cytolysis and cytokine production (Lanier, 2008; 
Vivier et al., 2011). 
 
The earliest interrogations into the function of NK cells led to the formulation of 
the “missing self hypothesis” (Kärre et al., 1986).  This hypothesis referred to 
another key distinction between adaptive cytotoxic T cells and innate NK cells.  
CD8+ T cells require interaction between the T cell receptor and cognate antigen 
presented by Major Histocompatibility Complex Class I (MHC Class I), to 
recognize target cells.  Killer T cells become blind to potential targets when target 
cells downregulate MHC Class I, a strategy employed by several viruses and 
tumors to evade the adaptive immune response.  Using implantable tumor lines 
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that either expressed host MHC, i.e. “self”, or lacked expression of self-MHC, 
Karre and colleagues found that tumors missing self appeared to exhibit 
enhanced susceptibility to natural killing (Kärre et al., 1986).  The study, 
however, could not rule out the possibility that the MHC Class I-deficient tumor 
not only lacked self but expressed an activating ligand for an as-yet-undefined 
NK cell receptor.  Later studies more specifically assayed the role of MHC 
deficiency on the activation of NK cells by employing a mouse genetically 
deficient in the β2m protein, critical for transporting Class I MHC to the cell 
surface (Bix et al., 1991; Liao et al., 1991; Zijlstra et al., 1989). It was observed 
that MHC-sufficient NK cells would reject haploidentical hematopoietic cells from 
the β2m–/– host in vitro and in vivo (Bix et al., 1991; Liao et al., 1991).  Further 
support for the missing self hypothesis came from investigations of hybrid 
resistance, a phenomenon in which the offspring of MHC-disparate parents 
would reject a bone marrow transplant from either parent (Kumar et al., 1997).  
Hybrid resistance was demonstrated in mice lacking adaptive immune 
lymphocytes, suggesting that this phenomenon was mediated by NK cells 
(Murphy et al., 1987).  Studies of the mechanism of NK-mediated hybrid 
resistance employed an MHC Class I transgene to formally test the role of self-
MHC.  Mice expressing Db Class I MHC rejected bone marrow from mice 
expressing Dd Class I MHC (Ohlén et al., 1989).  Marrow from Db mice 
expressing a Dd transgene was spared from rejection in Dd mice and Db x Dd 
hybrids.  Additionally, Db mice transgenic for Dd rejected Db marrow (Ohlén et al., 
1989).  Altogether, these data extended the missing self hypothesis and 
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suggested that hematopoietic cells were susceptible to NK-mediated killing if 
they lacked a full complement of self-MHC. 
 
The missing self hypothesis necessarily implied that NK cells could recognize, 
and were somehow inhibited by, Class I MHC.  But it failed to explain why NK 
cells from MHC Class I-deficient mice exhibited diminished killing activity in vitro 
and did not reject a bone marrow transplant from allogeneic mice (Liao et al., 
1991).  The missing self hypothesis predicts that β2m–/– mice would be not be 
deficient in NK cell activity.  Rather, MHC Class I-deficient mice should be riddled 
with hyperactive NK cells and NK-mediated autoimmunity.  Another shortcoming 
of the missing self hypothesis lies in the fact that hybrid progeny reject parental 
hematopoietic cells but accept parental solid organ transplants (Kumar et al., 
1997).  This observation suggested that NK activation was not controlled entirely 
by inhibitory signaling by self-MHC and that other, likely activating, stimuli played 
a key role in NK cell activation. 
 
Indeed, it has been appreciated that NK cells express a diverse array of 
activating and inhibitory receptors (Orr and Lanier, 2010; Vivier et al., 2011).  In 
the setting of target recognition, it is the net signals transmitted from activating 
and inhibitory receptors that determine NK cell activation.  Why, then, in the 
absence of inhibitory (self-MHC) signals in MHC Class I-deficient mice, do 
activating signals not predominate and result in widespread NK activation?  In 
addition to the original observations in β2m–/– mice, a battery of later studies all 
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pointed to the same phenomenon: similar to adaptive immune lymphocytes, NK 
cells appear to be “educated”, or tolerized to self (Orr and Lanier, 2010; Raulet 
and Vance, 2006; Joncker and Raulet, 2008; Vivier et al., 2011).  
 
Two prevailing, though partially opposing, models are believed to explain the 
phenomenon of NK cell tolerance.  The first, known as the “arming and disarming 
model” puts forth that NK cells are functionally “armed” by interactions between 
inhibitory receptors and cognate self-MHC (Raulet and Vance, 2006).  Functional 
“disarming” takes place when activating receptors are chronically stimulated in 
the absence of balancing inhibitory receptor signaling.  In other words, over-
stimulated NK cells can become functionally “anergic”.  The earliest evidence for 
the arming and disarming model came from work challenging wild-type/ β2m–/– 
mixed bone marrow chimeras with bone marrow allografts.  Whereas intact 
MHC-sufficient hosts would fully reject an MHC-deficient allograft, mixed 
chimeras generated on a wild-type background exhibited enhanced tolerance to 
MHC-deficient allografts (Wu and Raulet, 1997).  Mixed chimeras generated on a 
β2m–/– background accepted MHC-deficient allografts to an even greater degree.  
Thus, the presence of β2m–/– cells seemed to dominantly induce tolerance in 
wild-type NK cells that would otherwise lyse an MHC-deficient allograft (Wu and 
Raulet, 1997).  These data were consistent with the disarming model, in which 
repeated activating stimulation rendered NK cells hyporesponsive to further 
stimuli.  Additionally, it was observed that, in wild-type animals, NK cells can be 
found that lack any known inhibitory receptors but express activating receptors 
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(Fernandez et al., 2005).  Further support for the disarming model came from 
studies in which mice constitutively expressing activating NK ligands fostered 
hypoactive NK cells (Tripathy et al., 2008). 
 
A variant of the arming model, the “licensing model” describes a process by 
which NK cells become functionally competent only after engaging an inhibitory 
receptor with MHC Class I (Elliott and Yokoyama, 2011).  Evidence in support of 
licensing came from studying various inhibitory-receptor-expressing NK cells in 
allogeneic mice.  It was found that only NK cells bearing an inhibitory receptor 
that bound the MHC haplotype of the host were functionally competent upon 
stimulation (Kim et al., 2005). 
 
In mice, members of the Ly49 family of C-type lectin-like receptors recognize 
classical Class I MHC molecules (Hanke et al., 1999).  Ly49 receptors may be 
inhibitory or activating, depending on the character of the intracellular tail of the 
receptor.  Ly49A, Ly49C, Ly49G2, and Ly49I are examples of Ly49 family 
members that transduce signals through the immunoreceptor tyrosine-based 
inhibititory motif (ITIM) upon binding MHC Class I molecules (Lanier, 2008; Orr 
and Lanier, 2010; Vivier et al., 2011).  The inhibitory Ly49 receptors are those 
implicated in the arming and licensing models (Elliott and Yokoyama, 2011; 
Joncker and Raulet, 2008).  The activating Ly49 family member Ly49D 
transduces signals through an immunoreceptor tyrosine-based activating motif 
(ITAM) in response to cells expressing MHC Class I (Hanke et al., 1999).  Ly49H, 
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another activating Ly49 receptor, binds an MHC Class I-like molecule, m157 
(Arase et al., 2002).  Known as an MHC decoy, m157 is encoded by murine 
cytomegalovirus (MCMV) and sent to the cell surface, so that the infected cell 
may evade the host CD8+ T cell response.  The m157 protein stimulates NK 
cells, however, and it was observed that expression of Ly49H by NK cells was 
required to maintain resistance to MCMV infection (Lee et al., 2001).  Although 
additional NK receptors may play a secondary role in clearance of MCMV 
(Lodoen et al., 2003; Zafirova et al., 2009), mice lacking Ly49H-expressing NK 
cells cannot control early infection with  MCMV (Lee et al., 2001). 
 
Expressed by human NK (hNK) cells, the Ig superfamily members killer 
immunoglobulin-like receptors (KIRs) appear to be the functional homolog of 
murine Ly49 receptors. KIRs bind human leukocyte antigens (HLA), the 
equivalent of murine MHC, and transduce signals through intracellular ITIMs or 
ITAMs (Lanier, 2008).  An array of other receptors decorates the surface of 
murine and hNK cells, and many receptors are structurally and functionally 
homologous between the two species.  Major examples of orthologous NK 
receptors in mice and humans include the C-type lectin-like receptors NKG2A 
and NKG2D and the natural cytotoxicity receptor NKp46.  The heterodimeric 
NKG2A/CD94 is an inhibitory receptor that recognizes the non-classical self-
MHC molecule Qa-1b (Vance et al., 1998), believed to protect cells from lysis by 
NK cells expressing sufficient levels of NKG2A (Jia et al., 2000).  NKG2A-Qa-1b 
interactions may also play a key role in self-tolerance of neonatal NK cells 
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(Sivakumar et al., 1999), nearly devoid of activating and inhibitory Ly49 receptors 
(Kubota et al., 1999).  As opposed to NKG2A, NKG2D ligates several different 
molecules on the surface of target cells and transmits activating signals to the NK 
cell.  The common thread among NKG2D ligands is that they are all self-proteins 
upregulated by “stressed” cells, such as tumors (Diefenbach et al., 2000; Raulet, 
2003).  Of note, even though tumors may express a full complement of otherwise 
protective MHC Class I molecules, induction of NKG2D ligands dominantly 
renders these stressed cells susceptible to NK-mediated lysis (Cerwenka et al., 
2001; Diefenbach et al., 2001).  NKp46 is an activating receptor that was first 
cloned on hNK cells (Pessino et al., 1998).  NKp46 can activate NK cells after 
binding to viral hemagglutinins, typically encoded by influenza and parainfluenza 
viruses (Mandelboim et al., 2001). 
 
The studies of the landscape of NK cell surface receptors and the investigations 
into the nature of NK cell activation and inhibition suggest: 1) that armed/licensed 
NK cells are educated to self-ligands and thus reject targets missing self, 2) that 
upregulation of stressed self-ligands allows NK cells to break tolerance to self, 
and 3) that NK cells can directly recognize viral components and lyse infected 
cells.  Altogether, NK cells could be expected play critical roles in the control of 
certain viruses and tumors in humans.  Much of the evidence for the importance 
of NK cells in human immunity derives from studies in pediatric patients with NK 
cell abnormalities, such as functional impairment or outright deficiency (Lee et 
al., 2007; Orange, 2006).  A common theme in these subjects is increased 
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susceptibility to herpes viruses, including Herpes Simplex Virus, 
Cytomegalovirus, Epstein Barr Virus, Varicella Zoster Virus, and Papilloma Virus.  
These observations are consistent with the requirement for murine NK cells in 
MCMV infection.  While deficiency of hNK cells has a clear association with 
susceptibility to certain viruses, and while recognition of MCMV was found to be 
mediated directly by Ly49H, the mechanism by which hNK cells recognize and 
confer resistance to human herpesviruses is not yet known. 
 
Beyond controlling herpesviruses, hNK cells have been implicated in the 
response against several other infectious agents, including Hepatitis C Virus 
(HCV) and the Human Immunodeficiency Virus (HIV).  The data to support these 
claims stem from association studies of HCV- or HIV-infected individuals.  One 
such study reported that individuals homozygous for a combination of the NK 
receptor KIR2DL3 and the HLA molecule HLA-C1 were significantly protected 
from HCV disease progression, relative to heterozygous individuals or those not 
expressing any KIR2DL3/HLA-C1 (Khakoo et al., 2004).  Expression of HLA-C1 
by HCV-infected cells is advantageous due to the weak interaction between HLA-
C1 and KIR2DL3.  NK cells responding to HCV infection, thus, are relatively 
uninhibited to lyse the infected host cell.  Other recent studies have shed light on 
the role of NK cells in the control of HIV infection.  Combined expression of 
KIR3DS1 and HLA-B Bw4-80I was associated with reduced progression to AIDS, 
and enhanced reactivity of KIR3DS1+ hNK cells against HIV-infected, HLA-B 
Bw4-80I+ target cells was demonstrated subsequently in vitro (Martin et al., 2002; 
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Alter et al., 2007).  Further investigation revealed that NK cells appear to exert a 
selective pressure on HIV, resulting in the evolution of viral clones resistant to 
NK-mediated killing (Alter et al., 2011).  Specifically, polymorphisms in HIV 
proteins were found in KIR2DL2+ individuals that enhance binding of this 
inhibitory KIR to HIV-infected CD4+ T cells.  In turn, enhanced binding of 
KIR2DL2 to its HLA ligand on target cells results in reduced NK activation and 
impaired lysis of infected targets. 
 
In addition to playing a key role in antiviral immunity, NK cells also have known 
roles in human antitumor immunity.  One such role revolves around the ability of 
NK cells to reject hematopoietic cells missing self.  BM transplantation has been 
used commonly for the treatment of leukemia.  The major side effect of 
allogeneic BM transplantation is graft-versus-host disease, in which donor-
derived adaptive lymphocytes mount an immune response against recipient 
tissue.  By the same token, donor cytotoxic T cells also mediate a graft-versus-
leukemia effect, resulting in the elimination of host leukemic cells.  Investigations 
of humanized mouse models and of human association studies revealed that 
donor NK cells were key players in the graft-versus-leukemia phenomenon, 
rejecting host leukemic cells missing donor HLA molecules (Leung et al., 2004; 
Ruggeri et al., 2002).  Further, carefully considered KIR-mismatching appeared 
to be associated with improved outcomes in AML, including a substantial 
reduction in the rate of relapse. 
 
 10	  
Development and Homeostasis of NK Cells 
As innate lymphocytes, NK cells become functionally competent during 
development, which provides the host with cells primed to fight infection or 
cancer.  Like all lymphocytes, NK cells are of hematopoietic origin, so they 
necessarily derive from the hematopoietic stem cell.  By culturing purified 
populations of human hematopoietic progenitors in limiting dilutions, hNK cells 
were found to more immediately derive from a multipotent precursor with T, B, 
DC, and NK potential (Galy et al., 1995).  Similarly, adoptively transferred 
common lymphoid progenitors (CLPs) in the the mouse gave rise to T, B, and NK 
cells and could give rise to DCs under certain conditions (Kondo et al., 1997).  In 
various mouse models of CLP deficiency several groups noted that T and B 
lymphopoiesis were markedly impaired (He and Malek, 1996; Waskow et al., 
2002).  The size of the NK compartment in these mice, however, was unaffected 
(He and Malek, 1996; Waskow and Rodewald, 2002).  These data suggest that 
NK cells may be borne from a precursor other than the CLP, though the mouse 
models used may not reflect an absolute deficiency of CLPs. 
 
Most proximally, the bone marrow-resident natural killer progenitor (NKP) 
generates NK cells (Rosmaraki et al., 2001).  Phenotypically, NKPs are identified 
in the marrow as non-granular/non-lytic cells lacking classical markers of the T, 
B, NK, and myeloid lineages but expressing CD122, the beta chain of the 
interleukin-2 (IL-2) and interleukin-15 (IL-15) receptor complex.  NKPs lack the 
potential to give rise to T or B cells and are restricted to the NK lineage (Carotta 
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et al., 2011; Rosmaraki et al., 2001).  NKPs are believed to give rise to immature-
phenotype NK cells, which express the NK1.1 antigen and NKp46 and are 
heterogeneous for CD27 (Chiossone et al., 2009; Kim et al., 2002; Rosmaraki et 
al., 2001; Walzer et al., 2007).  Immature-phenotype NK cells may express some 
Ly49 family members and exhibit some lytic properties, including expression of 
the cytolytic effector molecules perforin and granzyme B (Kim et al., 2002; 
Rosmaraki et al., 2001).  Expression of integrin αv and the death ligand TRAIL in 
the steady state uniquely mark immature NK cells (Kim et al., 2002; Takeda et 
al., 2005).  Mature-phenotype NK cells, in contrast, lack expression of integrin αv 
and TRAIL and are instead marked by DX5, the antibody raised against the 
integrin CD49b.  DX5+ NK cells are highly proliferative in the steady state and 
express an unrestricted Ly49 repertoire.  Once DX5+, NK cells can further 
differentiate and upregulate the integrin CD11b.  Terminal differentiation of 
DX5+CD11bhigh NK cells occurs with induction of leukosialin (CD43) and KLRG-1 
and downregulation of CD27 (Chiossone et al., 2009; Kim et al., 2002; Robbins 
et al., 2004). 
 
The surface molecule common to all stages of NK cell development is CD122.  
Required for IL-15-responsiveness, the presence of CD122 on NK lineage cells 
from the NKP onward underscores the importance of IL-15 in the development 
and maintenance of NK cells.  Indeed, among IL-2, IL-4, IL-7, and IL-15, all 
cytokines that signal through the common-gamma signaling unit, only IL-15 was 
shown to have a significant effect on NK cell number beyond the NKP 
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(Vosshenrich et al., 2005).  In the setting of systemic absence of IL-15 or without 
expression on non-NK cells of IL-15Rα, which presents IL-15 in trans to the 
CD122/common-gamma complex (Dubois et al., 2002; Lodolce et al., 2001), NK 
cell homeostasis is severely impaired (Kennedy et al., 2000; Prlic et al., 2003).  
Partial rescue of NK cell development or homeostasis was noted with expression 
of IL-15Rα on dendritic cells alone (Castillo et al., 2009).  These data implicate 
accessory immune and non-immune cells in the presentation of IL-15 to NK cells. 
 
Transcription Factors in Differentiation and Maturation of NK cells 
Compared to cytokine deficiencies, transcription factor deficiencies have 
manifested more varied and informative developmental, phenotypic, and 
functional phenotypes in the NK cell compartment.  The earliest, most severe, 
and most specific impact on NK cell development was reported after deletion of 
the basic leucine zipper transcription factor E4BP4 (Nfil3).  Consistent with the 
induction of E4bp4 from the NKP stage to the immature-phenotype stage, the 
number of NKPs were not affected in the absence of E4BP4 (Gascoyne et al., 
2009).  Development past the NKP, however, was abrogated, as nearly no NK 
cells were found in any organs of E4bp4–/– mice (Gascoyne et al., 2009; 
Kamizono et al., 2009).  This relative phenocopy of mice deficient in IL-15 or IL-
15Rα prompted the authors to test whether E4BP4 might effect IL-15 signaling.  
E4bp4 was induced in immature- and mature-phenotype NK cells after exposure 
to IL-15 (Gascoyne et al., 2009).  Also, forced expression of E4BP4 in bone 
marrow progenitor cells led to partial rescue of NK cell development in Il15ra–/– 
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mice.  E4BP4 likely mediates aspects of NK development other than integration 
of IL-15 signals, though, as evidenced by the reduction in Id2 and Gata3 
expression in E4BP4-deficient NK cells (Gascoyne et al., 2009). 
 
Similar to NK cell development in the absence of E4BP4, NK development was 
substantially impaired in the absence of Id2 (Boos et al., 2007; Yokota et al., 
1999).  The DNA-binding protein inhibitor Id2 canonically inhibits basic helix-loop-
helix transcription factors, such as E2A proteins, which are required for B cell 
development (Bain et al., 1994; Sun et al., 1991; Zhuang et al., 1994).  Id2 
expression typifies true NKPs, devoid of T and B lineage potential (Boos et al., 
2007; Carotta et al., 2011).  Unlike E4BP4-deficient mice, Id2-deficient mice 
appeared to exhibit some development of immature-phenotype NK cells (Boos et 
al., 2007).  Additionally, loss of Id2 resulted in ablation of another lineage of 
innate lymphocytes, lymphoid tissue-inducer cells (LTi) (Boos et al., 2007; 
Yokota et al., 1999).  The incomplete defect in NK development may reflect some 
functional redundancy with another Id protein or with the DNA-binding factor 
TOX, the absence of which was also associated with a severe deficit in NK cells 
and LTis (Aliahmad et al., 2010).  Expression of Id2 was reduced in the absence 
of TOX, and forced expression of Id2 was unable to rescue NK cell development 
from Tox–/– progenitors.  These data are consistent with a model in which TOX is 
activated together with, or immediately downstream of, Id2 and reinforces the 
activity of Id2. 
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Several other transcription factors have been shown to alter the phenotype, 
functional capacity, and number of NK cells.  For instance, deletion of the Ets 
protein family member Ets-1 resulted in a reduction in the number of NK cells 
(Barton et al., 1998).  Ets1–/– NK cells lysed target cells poorly in vitro and in vivo 
and produced decreased amounts of interferon-gamma (IFN-γ) in response to 
stimulation in vitro.  Loss of another Ets protein, MEF, also resulted in a 
decreased number of NK cells (Lacorazza et al., 2002).  MEF-deficient NK cells 
also exhibited impaired production of IFN-γ and inefficiently lysed target cells in 
vitro.  The loss of lytic ability in the absence of MEF was attributed to direct 
regulation of the Prf1 gene, encoding the cytotoxic effector protein perforin, by 
MEF (Lacorazza et al., 2002).  Deficiency of a third member of the Ets family of 
transcription factors, PU.1, also was found to reduce the absolute number of NK 
cells (Colucci et al., 2001).  PU.1 is required for expression of Ly49A and Ly49D.  
PU.1 is dispensable, however, for NK cytotoxicity.  Finally, PU.1-deficient NK 
cells lack expression of the alpha chain of the interleukin-7 receptor (IL7Rα) 
(Colucci et al., 2001). 
 
Expression of IL7Rα was found to be a hallmark of cells derived from a GATA-3-
dependent, thymic pathway of NK cell differentiation (Vosshenrich et al., 2006). 
GATA-3 additionally appears to direct homing of NK cells to the liver (Samson et 
al., 2003).  And in contrast to its role in antagonizing production of IFN-γ in T 
cells (Ferber et al., 1999; Lee et al., 2000; Ouyang et al., 1998; Usui et al., 2003; 
Yagi et al., 2010), GATA-3 is essential for production of IFN-γ in NK cells.  This 
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severe defect in IFN-γ production by Gata3–/– NK cells manifested in vivo with 
Listeriosis early after infection with Listeria monocytogenes (Samson et al., 
2003), the control of which is dependent on NK cell-derived IFN-γ (Dunn and 
North, 1991).  Phenotypically, GATA-3-deficient NK cells lacked expression of 
Ly49D and appeared less mature, with a reduced percentage of Gata3–/– NK 
cells expressing CD11b and CD43 (Samson et al., 2003).  Loss of the zinc-finger 
transcriptional repressor Blimp-1 also resulted in impaired terminal differentiation 
of NK cells, as measured by surface expression of CD27, CD11b, and KLRG-1 
(Kallies et al., 2011).  Though per-cell levels of the cytolytic effector protein 
granzyme B (Gzmb) were reduced in the absence of Blimp-1, NK-mediated lysis 
of target cells was unaffected. 
 
Interferon regulatory factors (IRF) share some DNA binding sites with Blimp-1 
(Kuo and Calame, 2004), but deletion of IRFs have been reported to affect the 
development and function of NK cells in distinct ways from deletion of Blimp-1.  
IRF-1 was reported initially to be required for development and function of NK 
cells (Duncan et al., 1996; Ohteki et al., 1998), though it was found subsequently 
that IRF-1 is required for NK cell-extrinsic induction of IL-15 (Ogasawara et al., 
1998).  The IRF-1-deficient environment was thus inadequate to support 
development of wild-type-derived NK cells.   Conversely, IRF-1-deficient NK cells 
developed and functioned normally in an IL-15-sufficient environment 
(Ogasawara et al., 1998).  Loss of IRF-2, in contrast, affected the absolute 
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number and surface phenotype of NK cells in an NK cell-intrinsic fashion (Lohoff 
et al., 2000). 
 
 
T-box Transcription Factors in Differentiation of Cytotoxic Lymphocytes 
The T-box transcription factor T-bet was found originally to be required for 
commitment of CD4+ helper T (TH) cells to the Type 1 (TH1) lineage, 
characterized by production of IFN-γ (Szabo et al., 2002).  CD8+ cytotoxic T cells 
also were known to produce IFN-γ, but T-bet was dispensable for this aspect of 
CD8+ T cell effector function.  Eomesodermin (Eomes) is a T-box transcription 
factor that shares about 75% sequence homology with T-bet in the DNA-binding 
(T-box) region (Pearce et al., 2003).  Consequently, Eomes was found to be 
responsible for the T-bet-independent production of IFN-γ in CD8+ T cells.  It was 
later observed that T-bet and Eomes redundantly regulate the differentiation of 
naïve CD8+ T cells to Type 1 effector CD8+ T cells that elaborate IFN-γ and lyse 
target cells with perforin- and granzyme-containing granules (Intlekofer et al., 
2008).  In the absence of both T-bet and Eomes, effector CD8+ T cells produce 
interleukin-17 instead of IFN-γ and exhibit markedly diminished expression of 
cytolytic proteins. 
 
In addition to directly binding the gene loci for perforin and Gzmb, Eomes binds 
the promoter region of Il2rb and can drive expression of CD122 (Intlekofer et al., 
2005).  T-bet also drives expression of CD122, but to a lesser extent than does 
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Eomes.  IL-15-responsiveness is a key feature of CD8+ memory T cells (Kennedy 
et al., 2000), prompting further investigation into the expression patterns of T-bet 
and Eomes in the effector and memory phases of a CD8+ T cell-mediated 
immune response.  These and subsequent studies revealed non-redundant roles 
for T-bet and Eomes in specifying the fate of CD8+ effector and memory T cells, 
respectively.  The ratio of T-bet to Eomes expression is highest in CD8+ effector 
T cells (Intlekofer et al., 2005), consistent with the established role for T-bet in 
driving activated CD8+ T cells to adopt the effector fate (Intlekofer et al., 2007; 
Joshi et al., 2007).  In contrast, Eomes expression appears to dominate in CD8+ 
memory T cells (Intlekofer et al., 2005), consistent with the essential role for 
Eomes in developing or maintaining CD8+ memory T cells that are fit to compete 
for memory T cell niches (Banerjee et al., 2010).  Also independently of T-bet, 
Eomes is required for the uncontrolled proliferation of aberrant CD4–CD8– T cells 
in the setting of Fas/FasL deficiency (Kinjyo et al., 2010), as well as for the 
development of innate-like T cells (Gordon et al., 2011). 
 
Functionally, the CD8+ T cell and the NK cell are similar in several ways.  Both 
are cytolytic lymphocytes that can produce copious amounts of IFN-γ.  Also, both 
lineages depend on IL-15 for homeostatic turnover.  In light of these similarities, it 
is not surprising that both killer T cells and NK cells express T-bet and Eomes.  
Some aspects of NK cell differentiation, function, and homing are known to 
depend on T-bet.  As it has been suggested that T-bet directs CD8+ T cells 
toward terminal differentiation, so too is T-bet required for the terminal maturation 
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of NK cells, as measured by upreguation of CD43 and KLRG-1 and 
downregulation of CD27 (Jenne et al., 2009; Kallies et al., 2011; Soderquest et 
al., 2011; Townsend et al., 2004).  T-bet-deficient NK cells were found to exhibit 
a modest defect in IFN-γ production and target cell lysis, consistent with the 
direct regulation of the genes encoding IFN-γ, perforin, and Gzmb by T-bet 
(Szabo et al., 2002; Townsend et al., 2004).  Additionally, a role for T-bet in 
trafficking of NK cells was recently elucidated.  T-bet was found to bind the S1pr5 
gene, encoding the sphingosine-1-phosphate receptor S1P5, which promotes 
egress from the lymph nodes and bone marrow (Jenne et al., 2009).  Roles for 
Eomes in the differentiation and function of NK cells, however, have not been 
investigated. 
 
In this thesis work, I investigated the requirements for T-bet and Eomes in the 
development and function of NK cells.  I found novel roles for T-bet and Eomes 
as complementary gatekeepers of apparently successive checkpoints in the 
stepwise differentiation of NK cells.  Additionally, I have synthesized current 
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INTRODUCTION 
NK cells derive from hematopoietic progenitors.  A precursor that lacks 
expression of NK antigens but expresses CD122 (IL-2Rβ/IL-15Rβ) is believed to 
be committed to the NK lineage and restricted from other blood cell fates 
(Rosmaraki et al., 2001).  NK precursors generate NK antigen-bearing 
(NK1.1+NKp46+) immature NK cells that express the integrin αv and the death 
ligand TRAIL (Kim et al., 2002; Takeda et al., 2005; Walzer et al., 2007).  
Immature NK cells give rise to mature NK antigen-bearing cells, which repress 
integrin av and TRAIL and acquire the integrins CD49b (DX5+) and CD11b (Mac-
1) (Chiossone et al., 2009; Kim et al., 2002; Takeda et al., 2005).  Mature, DX5+ 
NK cells also express a diverse repertoire of Ly49 family receptors, which are 
responsible for educating NK cells to self-MHC and for enabling a broad 
specificity against microbial components (Kim et al., 2002; 2005; Orr and Lanier, 
2010). 
 
Development of adult NK cells is thought to take place predominantly in the bone 
marrow (Di Santo, 2006).  NK progenitors and NK developmental intermediates 
have also been identified in a variety of fetal and adult tissues.  Extramedullary 
niches that appear to foster NK development in mice and in humans include liver, 
lymph node, and thymus (Freud and Caligiuri, 2006; Luther et al., 2011; 
Vosshenrich et al., 2006).   
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The transcription factors Id2, Tox, and E4bp4 (Nfil3) are thought to specify the 
earliest stages of NK cell development (Aliahmad et al., 2010; Boos et al., 2007; 
Gascoyne et al., 2009; Kamizono et al., 2009).  Loss of various other 
transcription factors, including Ets-1, Gata-3, and PU.1 has been reported to alter 
NK cell number and phenotype (Barton et al., 1998; Colucci et al., 2001; Samson 
et al., 2003).  The precise hierarchy of transcription factors governing NK cell 
maturation, however, is incompletely understood.  The highly homologous T-box 
transcription factors Eomesodermin (Eomes) and T-bet direct fate and function in 
cytotoxic lymphocytes.  Eomes and T-bet redundantly regulate differentiation of 
CD8+ effector T cells (Intlekofer et al., 2005; 2008; Pearce et al., 2003).  Eomes 
and T-bet also appear to have non redundant functions in specifying the fate of 
CD8+ T cells (Banerjee et al., 2010; Intlekofer et al., 2007). 
 
It has been suggested that some aspects of terminal NK cell maturation are 
dependent on T-bet (Jenne et al., 2009; Townsend et al., 2004).  We now report 
an additional role for T-bet in stabilizing immature NK cell development.  The 
consequence of complete deletion of Eomes on NK cell development had not yet 
been determined.  We now show that maturation of NK cells to the stage 
characterized by expression of the integrin CD49b (DX5+) and acquisition of a 
diverse repertoire of activating and inhibitory Ly49 family receptors is dependent 
on Eomes.  Maintenance of NK cell maturity was also dependent on Eomes, 
although maintenance of Ly49 receptor expression occurred independently of 
Eomes.  Progenitors lacking both Eomes and T-bet could not support any NK 
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lineage development.  Taken together, our data support a model in which 
expression and function of T-bet and Eomes define the key, genetically 
separable molecular checkpoints of NK cell maturation. 
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RESULTS 
Eomes is required for NK cell maturation 
We first examined the expression of Eomes protein at the single-cell level.  The 
majority of NK cells expressed Eomes, but we detected a minor population of NK 
cells that were Eomes-negative (Eomes−) in each organ examined (Figure 2.1A; 
Supplementary Figure 2.1A).  The Eomes− population was most enriched in the 
liver.  A subset of less mature NK cells that express TRAIL and lack CD49b are 
present in neonates and preferentially reside in the adult liver (Takeda et al., 
2005).  We found that Eomes− cells are characterized by TRAIL expression, 
whereas Eomes+ cells are typified by CD49b expression (DX5+) (Figure 2.1A).  
Eomes– and Eomes+ NK cells also expressed different repertoires of homing 
receptors, consistent with their disparate anatomic localization. Eomes– but not 
Eomes+ NK cells expressed the Integrin αv and the chemokine receptors, CXCR3 
and CXCR6 (Figures 2.1B and 2.1C). 
 
To understand the requirements for Eomes in the development and homeostasis 
of NK cells, we utilized a hematopoietic-specific knockout of Eomes.  These mice 
harbored floxed alleles of Eomes (Intlekofer et al., 2008) and expressed Cre 
recombinase under control of Vav regulatory elements (Stadtfeld, 2004).  
EomesFl/Fl, Vav-Cre+ (Eomes cKO) mice had a substantial reduction of NK cells 
in the spleen and the blood, relative to wild-type animals (Figure 2.1D; 
Supplementary Figure 2.1B).  We observed a more modest reduction in NK cell 
number in the liver, lymph node, and bone marrow of Eomes cKO mice.  Deletion  
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Figure 2.1.  Eomes required for maturation of NK cells 
(A) Expression of Eomes and maturation markers TRAIL and DX5 in wild-type splenic and 
hepatic NK cells.  Plots represent CD3e–CD19–NK1.1+NKp46+CD122+ cells.  Data are 
representative of at least 5 separate experiments.  (B) Integrin av and CXCR3 expression on wild-
type hepatic NK cells.  Data are representative of at least 5 separate experiments.  (C) CXCR6 
expression on wild-type hepatic NK cells.  CXCL16-Fc binds to surface CXCR6 (Matloubian et al., 
2000).  CXCL16-Fc was detected by secondarily adding a biotin-conjugated, anti-human Fc 
antibody, followed by staining with fluorochrome-conjugated streptavidin.  Data are representative 
of 3 separate experiments.  (D) Analysis of splenic and hepatic NK compartments in wild-type 
and Eomes cKO mice, with quantification of absolute numbers of NK cells.  Data are 
representative of at least 5 independent experiments.  Error bars indicate standard deviation. *, 
p<0.05; **, p<0.001.  (E) Maturation markers TRAIL and DX5 in Eomes cKO, wild-type Eomes−, 
and wild-type Eomes+ NK cells.  Data are representative of 5 separate experiments.  (F and G) 
Ly49 repertoire of Eomes cKO NK cells, compared to wild-type Eomes− and Eomes+ NK cells.  
Data are representative of at least 3 separate experiments.  (H) Maturation markers CD27 and 
CD11b in Eomes cKO, wild-type Eomes−, and wild-type Eomes+ NK cells.  Data are 
representative of at least 3 separate experiments.  (I) Kinetic analysis of Eomes expression in NK 






































Supplementary Figure 2.1.  Cell-intrinsic requirement for Eomes in maturation of NK cells  
(A) Expression of Eomes in wild-type NK cells of indicated organs.  Data are representative of at 
least 5 separate experiments.  (B) Analysis and quantification of the NK compartments in 
indicated organs of wild-type and Eomes cKO mice.  Data are representative of 3-5 independent 
experiments.  Error bars indicate standard deviation.  n.s., not significant, p>0.05; ***, p<0.001.  
(C) Maturation marker expression on wild-type and Eomes cKO NK cells in indicated organs.  (D, 
E, and F) Ly49 repertoire expression on wild-type and Eomes cKO NK cells.  Data are 
representative of at least 3 separate experiments.  (G and H) Analysis of maturation markers 
TRAIL (G) and DX5 (H) on NK cells isolated from wild-type (CD45.1+) plus Eomes cKO 
(CD45.2+) mixed bone marrow chimeras, 6-10 weeks post-bone-marrow-transplant.  Data are 
representative of analyses from at least 3 individual mice. 
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of Eomes appeared to affect NK numbers in organs that normally contain greater 
numbers of mature, DX5+ NK cells.  We, therefore, interrogated the phenotype of 
NK cells remaining in the absence of Eomes.  NK cells from Eomes cKO mice 
approximated the phenotype of immature, Eomes− NK cells from wild-type mice, 
expressing TRAIL but lacking CD49b as well as Ly49A, Ly49D, Ly49G2, and 
Ly49H (Figures 2.1E, 2.1F, and 2.1G; Supplementary Figures 2.1C, 2.1D, 
2.1E, and 2.1F).  NK cells from Eomes cKO mice and immature, Eomes− NK 
cells from wild-type mice do, however, efficiently express Ly49C and/or Ly49I 
(Figure 2.1F).  Eomes cKO and wild-type Eomes− NK cells also shared the 
immature, CD27highCD11blo phenotype (Figure 2.1H).  The requirement for 
Eomes to develop mature, DX5+ NK cells appeared to be cell-intrinsic.  Wild-type 
plus Eomes cKO mixed bone marrow chimeras were generated and analyzed for 
NK cell composition.  Eomes cKO marrow efficiently contributed to the immature, 
TRAIL+ NK cell lineage, but Eomes-deficient marrow did not contribute to the 
mature, DX5+ NK cell compartment (Supplementary Figures 2.1G and 2.1H).  
These data suggest that Eomes is an intrinsic and non-redundant regulator of the 
genetic program of NK cell maturation. 
 
Neonatal NK cells lack markers of maturity and express limited Ly49 receptor 
repertoires (Kubota et al., 1999; Takeda et al., 2005), somewhat akin to NK cells 
in adult Eomes cKO mice.  We observed that NK cells from neonatal mice have 
minimal expression of Eomes (Figure 2.1I).  We also found that postnatal NK 
cells in the spleen initiated Eomes expression more readily than did hepatic 
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neonatal NK cells.  The delayed onset and anatomic bias of Eomes expression is 
consistent with prior developmental kinetic analysis indicating that NK maturation 
to the DX5+ stage is evident after the postnatal period and occurs preferentially 
outside the liver (Takeda et al., 2005).  Whether the early splenic environment 
contains signals that promote the induction of Eomes or simply lacks hepatic 
signals that restrict Eomes induction remains to be determined.  Our data support 
a model wherein progenitors lacking Eomes arrest at an immature stage of NK 
cell development, unable to progress to the Ly49- and CD49b-expressing (DX5+) 
stage of maturation that characterizes most adult NK cells. 
 
Eomes– NK cells can give rise to Eomes+ NK cells 
Eomes appears to direct NK maturation past the TRAIL+Integrin αv+ state to the 
CD49b-expressing (DX5+) state.  Whether Eomes– NK cells are the direct 
predecessors of Eomes+ NK cells has not been determined.  Analyses of NK cell 
developmental stages in the bone marrow and cell transfer experiments using 
defined intermediates are compatible with a model wherein TRAIL+Integrin αv+ 
NK cells may give rise to DX5+ NK cells (Chiossone et al., 2009; Kim et al., 2002; 
Takeda et al., 2005).  To address whether TRAIL+ NK cells can upregulate 
Eomes while maturing into DX5+ NK cells, we FACS-sorted immature, TRAIL+ 
NK cells to 97% purity and transferred them into unirradiated, immunodeficient 
Il2rg-/-, Rag2-/- (Gamma-common, Rag double KO) mice, which lack NK cells and 
lymphocytes.  One (Figure 2.2A) or two (Figure 2.2B) weeks following adoptive 









Figure 2.2.  Eomes– NK cells can give rise to Eomes+ NK cells 
Highly purified TRAIL+ and DX5+ donor NK cells were adoptively transferred into Gamma-
common, Rag double KO recipients.  One (A) or two (B) weeks post-transfer, indicated organs of 
recipient mice were harvested and NK cells were analyzed for expression of Eomes, Ly49 












KO recipients were analyzed for the presence of NK cells.  We found that DX5+ 
NK cells remain DX5+, Eomes+, and Ly49+ after adoptive transfer (Figures 2.2A 
and 2.2B), consistent with prior experiments showing stability of CD49b 
expression (Takeda et al., 2005).  Acquisition of Eomes expression in the 
mature, DX5+ stage of NK cell development, thus, appears to be a stable event. 
 
Transferred immature, TRAIL+ NK cells underwent in vivo maturation 
characterized by repression of TRAIL and induction of CD49b (DX5+), Eomes, 
and Ly49 receptors (Figures 2.2A and 2.2B).  NK cell maturation and induction 
of Eomes was restricted in the liver, promoted in the spleen, and favored most in 
the bone marrow.  The anatomical hierarchy of induction of Eomes in the NK cell 
lineage mirrors the findings that NK cell maturation is a developmentally 
regulated event.  Expression of Eomes and maturation from TRAIL+ to the DX5+ 
Ly49+ NK cell lineage appears to be delayed until the postnatal period, when the 
primary site of hematopoiesis shifts from the liver to the bone marrow (Keller et 
al., 1999). 
 
Eomes maintains maturity of NK cells 
Induction of Eomes appears to be required to establish the mature NK cell state.  
To investigate the role of Eomes in maintaining NK cells in the mature state, we 
temporally deleted Eomes from mature NK cells.  Splenic NK cells with floxed 
alleles of Eomes were isolated and treated directly ex vivo with Cre-recombinase 
fused to the transduction domain of the HIV TAT protein (TAT-Cre) (Wadia et al., 
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2004).  Cells were exposed to TAT-Cre for 45 minutes to allow TAT to chaperone 
Cre across the cell and nuclear membranes.  Intranuclear Cre protein could then 
excise the floxed portion of Eomes.  The protein transduction reaction was 
quenched by addition of fetal bovine serum followed by thorough washing.  
Treated or sham-treated cells were then adoptively transferred into unirradiated 
Gamma-common, Rag double KO mice.   
 
One week after cell transfer, we analyzed the NK cell compartments of recipient 
mice.  From recipients of sham-treated cells, we retrieved mature, Eomes+DX5+ 
NK cells that expressed diverse Ly49 receptors and immature, Eomes–TRAIL+ 
NK cells that displayed a paucity of Ly49 receptor expression (Figures 2.3A and 
2.3B).  Based on the failure of Eomes+DX5+ NK cells to convert to Eomes–
TRAIL+ NK cells (Figure 2.2), we attribute the presence of a sizeable Eomes– 
population to vigorous expansion of pre-existing Eomes–TRAIL+ NK cells in the 
donor organs. From recipients of TAT-Cre-treated cells, we retrieved an 
additional population of Eomes– cells that expressed Ly49 receptors.  Because 
the Eomes−Ly49+ state did not arise in sham-treated cells, this subset 
presumably represented the formerly mature, Eomes+DX5+ NK cells that 
underwent Cre-mediated deletion of Eomes (Figures 2.3A and 2.3B).  The 
stability of all Ly49 family members examined in cells lacking Eomes protein over 
the interval of the cell transfer suggested that maintenance of Ly49 receptor 
expression may not be dependent on Eomes, even though establishment of Ly49 
























Figure 2.3.  Eomes required to maintain some aspects of mature NK cells 
Splenic NK cells with floxed alleles of Eomes were purified and either treated with TAT-Cre or 
sham-treated directly ex vivo.  Donor cells were transferred into Gamma-common, Rag double 
KO recipients and analyzed 7-10 days later.  (A) NK cells from spleens of recipient mice were 
analyzed for expression of Eomes and indicated Ly49 receptors.  Data are representative of at 
least 2 separate experiments.  (B) NK cells from livers of recipient mice were analyzed for Ly49 
receptor expression (top row).  Ly49+ NK cells were also analyzed for maturation markers TRAIL 
and DX5 (bottom row).  Data are representative of 5 separate experiments. 
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In contrast to the stability of Ly49 expression, we found that temporal deletion of 
Eomes resulted in loss of many of the other markers of maturity.  Ly49+ NK cells 
that retained expression of Eomes after treatment with TAT-Cre exhibited a 
mature phenotype (TRAIL–DX5+) (Figure 2.3B).  A substantial proportion of 
Ly49+ NK cells that lost expression of Eomes became TRAIL+ and DX5-.  We 
also observed partial derepression of Integrin αv and CXCR6 in Ly49+ NK cells 
after loss of Eomes (Supplementary Figure 2.2).  These findings suggest that 
Eomes directly or indirectly represses the immaturity markers TRAIL, Integrin αv, 
and CXCR6, while inducing the maturity marker CD49b (DX5+).  Mature, 
Eomes+DX5+ NK cells normally retain their TRAIL–DX5+ identity (Figure 2.2), but 
loss of Eomes can cause mature cells to become immature, TRAIL+ DX5-, 
despite their maintenance of Ly49 receptors (Figure 2.3B).  The reversion in 
attributes after temporal deletion of Eomes complements the prior findings 
suggesting that immature, Eomes–TRAIL+ NK cells can be in vivo intermediates 
that give rise to mature Eomes+DX5+ NK cells (Figure 2.2).  Together, these 
experiments provide forward and reverse evidence that acquisition of Eomes 
elaborates and maintains mature attributes onto the immature NK cell foundation.  
 
T-bet stabilizes Eomes– NK cells 
To evaluate the role of T-bet in NK cell development, we compared the 
phenotypes and patterns of T-box protein expression in NK lineages of Eomes 
cKO and Tbx21-/- (T-bet KO) mice.  Tissues from T-bet KO mice only contained 






Supplementary Figure 2.2.  Eomes maintains repression of immature NK cell markers 
Splenic NK cells with floxed alleles of Eomes were purified and either treated with TAT-Cre or 
sham-treated directly ex vivo.  Donor cells were transferred into Gamma-common, Rag double 
KO recipients and analyzed 7-10 days later.  NK cells from livers of recipient mice were analyzed 
for expression of Eomes and Ly49D and/or Ly49G2 (top row).  Ly49D+ and/or Ly49G2+ NK cells 
were also analyzed for expression of integrin αv (middle row) and CXCR6 (bottom row).  Data are 
representative of 2 separate experiments. 
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Eomes (Figures 2.4A and 2.4B; Supplementary Figures 2.3A and 2.3B).  
Immature, Eomes–TRAIL+ NK populations were seemingly absent from T-bet KO 
mice, while TRAIL+ cells represented the predominant NK population of Eomes 
cKO mice.  T-bet KO and Eomes cKO mice thus have reciprocal maturational 
phenotypes: T-bet KO mice lack immature (DX5-) cells, while Eomes cKO mice 
lack mature (DX5+) NK cells.   
 
T-bet is normally expressed in both Eomes– and Eomes+ NK cells (Figure 2.4B; 
Supplementary Figure 2.3A), which is consistent with roles for T-bet in both 
immature and mature NK cell stages.  In addition to playing an essential role in 
stabilizing the immature, DX5– subset (Figure 2.4A), T-bet controls repression of 
CD27 and induction of CD43 in mature, CD11bhighDX5+ NK cells (Supplmentary 
Figure 2.3C), as has been previously suggested (Jenne et al., 2009; Townsend 
et al., 2004).  Although mature, DX5+ NK cells can develop without T-bet, the 
terminal stages of maturation are incomplete in the absence of T-bet.  Using wild-
type plus T-bet KO mixed bone marrow chimeras, we found that the previously 
described role for T-bet in repressing CD27 among mature NK cells and the 
newly described role for T-bet in development or maintenance of the immature, 
TRAIL+Eomes–DX5– NK population were both cell-intrinsic effects 
(Supplementary Figures 2.3D, 2.3E, and 2.3F). 
 
The lack of immature, TRAIL+ NK cells in the absence of T-bet could be 








Figure 2.4.  T-bet stabilizes immature, Eomes– NK cells  
(A and B) Expression of maturation markers TRAIL and DX5, along with expression of T-bet and 
Eomes, in wild-type, Eomes cKO, and T-bet KO hepatic NK cells.  Data are representative of at 
least 5 separate experiments.  (C) Effect of acute loss of T-bet in NK cells.  Hepatic NK cells with 
floxed alleles of Tbx21 were purified and either treated with TAT-Cre or sham-treated directly ex 
vivo.  Donor cells were transferred into Gamma-common, Rag double KO recipients and 
analyzed 7-10 days later. NK cells from livers of recipient mice were analyzed for expression of 
Eomes and Ly49 receptors.  Data are representative of 2 separate experiments.  (D) 
Developmental analysis of hepatic and splenic NK cell compartments in wild-type and T-bet KO 
mice of indicated ages.  Day 0 (d0) denotes the day of birth.  Data are representative of at least 5 
separate experiments.  (E) Quantification of absolute number of NK cells in wild-type and T-bet 
KO neonatal mice, aged d0 to d2.  Error bars indicate standard deviation.  **, p<0.001; ***, 
p<0.0001.  (F) Effect of loss of T-bet and/or Eomes on hepatic and splenic NK cell compartments.  
Data are representative of 2 separate experiments.  (G) Effect of acute loss of Eomes in T-bet-
deficient NK cells.  Splenic Tbx21+/+ or Tbx21-/- NK cells with floxed alleles of Eomes were purified 
and either treated with TAT-Cre or sham-treated directly ex vivo.  Donor cells were transferred 
into Gamma-common, Rag double KO recipients and analyzed 7-10 days later.  NK cells from 
livers of recipient mice were analyzed for expression of Eomes and Ly49 receptors.  Data are 














Supplementary Figure 2.3.  T-bet stabilizes Eomes– NK cells in a cell-intrinsic fashion but 
does not specify NK precursors 
(A) T-bet and Eomes expression in NK cells isolated from indicated organs of wild-type, Eomes 
cKO, and T-bet KO mice.  Data are representative of at least 3 separate experiments.  (B) Ly49 
repertoire of splenic NK cells from mice of indicated genotypes.  Data are representative of at 
least 3 separate experiments.  (C) Expression of maturation markers CD11b, CD27, and CD43 
on bone marrow-resident NK cells from mice of indicated genotypes.  Data are representative of 
at least 3 separate experiments.  (D, E, and F) Expression of T-bet and Eomes (D), as well as 
maturation markers TRAIL (E), CD27 and CD11b (F), in NK cells isolated from indicated organs 
of wild-type (CD45.1+) plus Eomes cKO (CD45.2+) mixed bone marrow chimeras, 6-10 weeks 
post-bone-marrow-transplant.  Data are representative of analyses from 3-5 individual mice.  (G) 
Effect of acute loss of T-bet on Eomes expression.  Hepatic NK cells with floxed alleles of Tbx21 
were purified and either treated with TAT-Cre or sham-treated directly ex vivo.  Donor cells were 
transferred into Gamma-common, Rag double KO recipients and analyzed 7-10 days later.  
Hepatic NK cells were analyzed for expression of Eomes.  Data are representative of 2 separate 
experiments.  (H) Quantification of NK precursors (NKPs, intracellular and extracellular CD3ε–, 
CD19–Gr-1–Ter119–NK1.1–DX5–, CD122high) cells in wild-type, T-bet KO, Eomes cKO, and DKO 
mice.  Error bars indicate standard deviation.  n.s., not significant, p>0.05.  (I) NK1.1– NK 
precursor cells (NKP) and NK1.1+ NK cells (NK) were purified from wild-type bone marrow and 
analyzed for expression of Tbx21 and Eomes mRNA by qRT-PCR. 
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cells.  We tested whether T-bet is required for the stability of the TRAIL+ subset.  
T-bet was temporally deleted by treating hepatic NK cells harboring floxed alleles 
of Tbx21 with TAT-Cre ex vivo.  Treated or sham-treated cells were adoptively 
transferred into unirradiated Gamma-common, Rag double KO mice.  One week 
later, we harvested and analyzed the NK compartments of the recipients.  From 
recipients of sham-treated cells, we recovered both immature, Eomes–TRAIL+ NK 
cells and mature, Eomes+ NK cells (Figure 2.4C).  From recipients of TAT-Cre-
treated cells, we detected a sizeable population of NK cells that lost expression 
of T-bet (Supplementary Figure 2.3G).  TAT-Cre-treatment markedly 
diminished the presence of immature, Eomes–TRAIL+ NK cells while not 
seemingly affecting the recovery of mature, Eomes+ NK cells (Supplementary 
Figure 2.4C).  Whether the loss of T-bet simply caused immature, Eomes–
TRAIL+ cells to perish or, instead, catalyzed their conversion to mature, Eomes+ 
NK cells has not been determined.  Accelerated maturation from the loss of T-bet 
might be possible owing to the finding that NK cells from which T-bet was acutely 
(Supplementary Figure 2.3G) or chronically (Supplementary Figure 2.3A) 
deleted both exhibited increased levels of Eomes expression.  Whether by 
enabling its formation, maintaining its survival, or curbing its progressive 
maturation, the present findings suggest that T-bet stabilizes the immature, 
Eomes–TRAIL+ stage of NK cell development. 
 
T-bet appears required to stabilize immature NK cells, and immature NK cells are 
the predominant NK cells in the perinatal period (Takeda et al., 2005).  We, 
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therefore, examined the NK compartment in neonatal mice.  T-bet KO neonates 
possessed substantially reduced NK cell numbers relative to age-matched, wild-
type control mice (Figures 2.4D and 2.4E).  These data support a model in which 
immature neonatal NK cells depend on T-bet for development or stability.  
Because the neonatal environment is restrictive for Eomes induction, there does 
not appear to be precociously accelerated NK cell maturity at this stage of life. 
 
T-bet or Eomes is required for an NK lineage cell to be maintained 
The data presented thus far suggest that T-bet and Eomes are required to 
stabilize sequential or alternative stages of NK cell maturation.  We intercrossed 
Eomes cKOs with T-bet KOs to yield Tbx21-/-EomesFlox/Flox, Vav-Cre+ (DKO) 
animals, lacking both Eomes and T-bet in the hematopoietic compartment.  We 
could not detect NK cells in any organ of the DKO animals (Figure 2.4F).  
Despite the absence of NK antigen-expressing NK lineage cells, we found that 
NK antigen-negative precursors of NK cells were present in DKO mice 
(Supplementary Figure 2.3H).  The apparent lack of requirement of T-bet and 
Eomes to develop NK lineage-committed precursors is consistent with the low 
levels of T-bet and Eomes gene expression in wild-type NK precursors 
(Supplementary Figure 2.3I). 
 
Eomes-dependent NK cells can revert to an apparently less mature state, after 
loss of Eomes (Figure 2.3).  To determine whether this reverted state is T-bet-
dependent, we temporally deleted floxed alleles of Eomes on a T-bet KO 
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background.  Eomesflox/floxTbx21-/- cells were treated with TAT-Cre ex vivo, 
washed, and adoptively transferred into unirradiated Gamma-common, Rag 
double KO mice.  Treated Eomesflox/flox NK cells on a T-bet-sufficient background 
lost expression of Eomes and persisted in recipient mice (Figure 2.4G).  By 
contrast, T-bet-deficient NK cells that underwent temporal deletion of Eomes 
could not exist as a stable population in recipient mice.  Thus, the absence of T-
bet and Eomes results in the loss of immature and mature NK cells, respectively.  
The absence of both factors, however, is incompatible with a stable NK-antigen-
bearing NK cell. 
 
Expression of effector genes by Eomes– and Eomes+ NK cells 
Eomes−TRAIL+ and Eomes+DX5+ NK cells are dependent on distinct T-box 
transcription factors and exhibit distinct surface phenotypes.  Whether immature 
and mature NK cells express similar functional genes has not been fully 
determined.  NK cells kill targets by releasing cytotoxic granules or engaging 
death receptors (Smyth et al., 2005).  We examined the expression of molecular 
effectors of cytolysis in immature and mature NK cells.  Quantitative, real-time, 
reverse transcriptase PCR (qRT-PCR) was performed on purified TRAIL+ and 
DX5+ NK cells.  We found that TRAIL+ cells expressed moderately less Perforin 
(Prf1) mRNA than DX5+ cells (Figure 2.5A), consistent with a role for Eomes in 
inducing Prf1 (Cruz-Guilloty et al., 2009; Intlekofer et al., 2005; Pearce et al., 
2003).  Despite the reduction relative to DX5+ NK cells, levels of Prf1 in TRAIL+ 






















Figure 2.5.  Effector gene expression of Eomes– and Eomes+ NK cells 
(A) Eomes, Prf1, and Gzmc mRNA expression in purified TRAIL+ and DX5+ NK cells.  Error bars 
indicate standard error of the mean (SEM).  Data are representative of 3 separate experiments.  
(B) Expression of Granzyme B (Gzmb) in wild-type, unstimulated hepatic NK cells.  Data are 
representative of 3 separate experiments.  (C) Analysis of degranulation by wild-type hepatic NK 
cells in vitro.  Hepatic lymphocytes were isolated and stimulated with PMA/Iono for 4 hours in 
vitro in the presence of anti-CD107a antibody.  Data are representative of 3 separate 
experiments.  (D) Expression of IFN-γ in wild-type hepatic NK cells after stimulation with 
recombinant IL-12 and IL-18 for 4 hours in vitro.  Data are representative of 3 separate 
experiments.  (E) Tnf mRNA expression in wild-type, unstimulated, highly-purified TRAIL+ and 
DX5+ NK cells.  Error bars indicate standard error of the mean (SEM).  Data are representative of 
3 separate experiments.  (F) Expression of TNF-α in wild-type hepatic NK cells after stimulation 


























Supplementary Figure 2.4.  Expression of effector molecules and inhibitory receptors by 
Eomes− and Eomes+ NK cells 
(A) Expression of Prf1 mRNA by qRT-PCR in indicated groups of cells.  Wild-type TRAIL+ NK 
cells and DX5+ NK cells were purified from the livers of uninfected mice.  CD8+ naïve 
(CD44loCD62Lhi) T cells were purified from the spleens of uninfected mice.  CD8+ effector T 
(CD44higp33-Tetramer+) cells were purified from the spleens of mice infected 8 days prior with 
lymphocytic choriomeningitis virus. Data are representative of 2 separate experiments.  (B) 
NKG2A expression on splenic NK cells from wild-type and Eomes cKO mice.  Data are 
representative of 2 separate experiments. 
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TRAIL+ NK cells expressed increased levels of Granzyme C (Gzmc) mRNA, 
relative to Eomes+DX5+ NK cells (Figure 2.5A).  Both subsets from the liver 
stained brightly for Granzyme B protein (Figure 2.5B).  To test whether Eomes–
TRAIL+ NK cells can degranulate, we stimulated hepatic lymphocytes briefly with 
phorbol myristolate acetate and ionomycin (PMA/Iono) in vitro.  Cells were 
cultured in the presence of anti-CD107a (lysosomal-associated membrane 
protein-1, LAMP-1) antibody to assess degranulation (Alter et al., 2004).  We 
found that both Eomes– and Eomes+ NK cells efficiently de-granulate (Figure 
2.5C).  
 
NK cells also release proinflammatory cytokines, such as IFN-γ and TNF-α, in 
response to stimuli (Vivier et al., 2011).  We found that Eomes− and Eomes+ NK 
cells express IFN-γ after stimulation with IL-12/IL-18 (Figure 2.5D), consistent 
with a prior analysis of TRAIL+ versus DX5+ NK cells (Takeda et al., 2005).  The 
Eomes−TRAIL+ subset expressed higher levels of basal TNF-α (Tnf) mRNA 
(Figure 2.5E) and contained higher levels of TNF-α protein after stimulation with 
PMA/Iono (Figure 2.5F).   
 
NK cells specifically kill target cells and spare healthy host cells (Orr and Lanier, 
2010).  Various receptors, including Ly49 family members and NKG2A, have 
been implicated in educating NK cells to self.  NKG2A binds the nonclassical 
MHC class I molecule Qa-1b and may participate in tolerizing NK cells to self 
(Vance et al., 1998).  Neonatal NK cells express inhibitory receptors but lack 
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activating receptors (Kubota et al., 1999).  Eomes– NK cells expressed similar 
levels of NKG2A and at similar frequencies to Eomes+ NK cells (Supplementary 
Figure 2.4B).  We found that Eomes– NK cells also expressed Ly49C and/or 
Ly49I (Figure 2.1), which bind MHC Class I ligands in C57BL/6 mice (Brennan et 
al., 1996a; 1996b; Liu et al., 2000).  Immature, Eomes– NK cells, thus, appear to 
be educated to self MHC and licensed to identify and kill targets that are missing 
self (Kim et al., 2005), which is consistent with prior analysis suggesting that both 
TRAIL+ and DX5+ NK cells can lyse YAC-1 target cells in vitro (Takeda et al., 
2005) and our own preliminary findings that Eomes-deficient mice can clear 
target cells that are missing self in vivo.  The functional significance of the 
observed differences in expression of effector molecules by immature and 
mature NK cells (Perforin, Granzyme C, TNF-α, etc.) has yet to be determined. 
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DISCUSSION 
Developing NK cells are believed to derive from lymphoid progenitors (Spits and 
Di Santo, 2011).  Restriction of B cell potential and commitment to the innate 
lymphoid lineage appears to be mediated by Id2 (Boos et al., 2007; Carotta et al., 
2011).  Id2-expressing NK precursors may give rise to canonical NK cells in an 
E4bp4- and Tox-dependent fashion (Aliahmad et al., 2010; Carotta et al., 2011; 
Gascoyne et al., 2009; Kamizono et al., 2009).  Previous studies have elucidated 
various phenotypic stages of NK cell development and maturation (Chiossone et 
al., 2009; Kim et al., 2002; Takeda et al., 2005), but the molecular events that 
control passage through these stages are not fully understood. 
 
We found that NK cell development is profoundly impaired in the absence of both 
Eomes and T-bet.  The phenotypes of T-bet KO mice and Eomes cKO mice are 
not, however, identical.  Each single KO mouse exhibited a substantial loss of NK 
cells.  The most striking defect in each case was the loss of a distinct and non-
overlapping phenotypic subset from that lacking in the other knockout mouse.  
Roughly, the double KO phenotype approximated the addition of the two single 
KO phenotypes. 
 
Our data support a model wherein NK precursors may upregulate T-bet and 
transit to an immature, Eomes−DX5−TRAIL+T-bet+ state.  This developmental 
sequence seems to be the predominant, if not exclusive, manner of NK cell 
development in embryogenesis and in neonates, when hematopoiesis is 
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predominantly occurring in the liver (Keller et al., 1999).  Immature-phenotype, 
Eomes−DX5−TRAIL+T-bet+ NK cells persist in adulthood, predominantly as a 
stable lineage in the liver and as a more mercurial intermediate that transits to a 
mature stage in the bone marrow (Kim et al., 2002; Takeda et al., 2005).  
Importantly, the immature, DX5−TRAIL+ NK cell identity appears strictly 
dependent on T-bet, but not Eomes, for its stability.  Whether immature NK cells 
in the adult liver arise de novo from NK precursors in the adult liver, represent 
homeostatic divisions of immature NK cells that developed early in life, are 
migrants from the bone marrow, or possess some other ontogenic history 
remains to be determined.  Transfer studies presented herein indicate that the 
liver remains a non-permissive environment for induction of Eomes in NK cells 
throughout the lifetime of the organism. 
 
Our findings support a model for a different scenario in adult hematopoiesis, 
which occurs predominantly in the bone marrow.  NK precursors appear to give 
rise to a similarly immature-appearing, Eomes−DX5−TRAIL+T-bet+ stage.  This 
intermediate appears to yield subsequent stages of maturation that we now show 
are strictly dependent on the expression and function of Eomes.  The Eomes-
dependent phenotypic properties of mature, Eomes+DX5+TRAIL−T-bet+ NK cells, 
including repression of TRAIL and expression of CD49b (DX5+), also require 
ongoing Eomes activity to retain this identity.  Establishment of the Ly49 
repertoire of mature NK cells is genetically downstream of Eomes function, but 
the Ly49 repertoire appears to remain fixed after the loss of Eomes.  Chromatin 
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modifications and DNA methylation changes have been suggested to mark the 
activity of Ly49 family members (Rouhi et al., 2006; 2007).  The characteristic 
heritability of developmentally induced epigenetic modifications is a plausible 
mechanism to explain why Eomes appears to be required for establishment but 
not maintenance of the Ly49 repertoire. 
 
One of the unresolved features of the present model is whether all mature, 
DX5+TRAIL– NK cells transit through a DX5−TRAIL+ intermediate stage or 
whether the Eomes-dependent DX5+ state is an alternative lineage to the T-bet-
dependent TRAIL+ state.  The finding that NK cells from T-bet KO mice can 
seemingly “short-circuit” the TRAIL+ intermediate to become mature, DX5+ NK 
cells could be interpreted in at least two ways.  In the linear model, it could be 
envisioned that T-bet is essential to stabilize the TRAIL+ state but that this stage 
still exists, albeit unstably, in the absence of T-bet.  In this scenario, fate-mapping 
experiments where cells are indelibly marked if they once expressed TRAIL 
would reveal all DX5+ NK cells marked by history of TRAIL expression.  In a 
bifurcative model, NK precursors might become DX5+Eomes+ NK cells without 
passing through a TRAIL+ intermediate.  In this scenario, fate-mapping of DX5+ 
NK cells would reveal mature cells unmarked by a history of TRAIL expression.  
The expression of T-bet in mature, DX5+ NK cells may instead be a late event 
that arises for the purpose of T-bet to regulate the most terminal aspects of NK 
cell maturation such as expression of CD43, KLRG1, S1P5, and repression of 
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CD27 (Jenne et al., 2009; Townsend et al., 2004).  Future experiments involving 
creation of novel mouse models will be needed to resolve this issue. 
 
Why the fetal and neonatal NK repertoire consists predominantly of immature NK 
cells remains unresolved.  The paucity of Ly49 receptors on early neonatal NK 
cells (Kubota et al., 1999) can now be linked to the restriction on Eomes 
induction in the hepatic hematopoietic compartment.  Future experiments 
involving enforced Eomes expression within the immature, TRAIL+ stage will, 
thus, be informative for determining whether there is an undesirable 
consequence of maturation of the Ly49 repertoire in early development. 
Activation or tolerization of fetal NK cells through exposure to maternal or self-
components with different or low levels of MHC molecules might be reasons that 
repertoire selection of NK cells is delayed until after birth (Kumar et al., 1997; 
Tripathy et al., 2008).  Both humans and mice are highly susceptible to 
devastating, often fatal infection with herpesviruses in the perinatal period, owing 
partly to deficiency in NK cell-mediated antiviral responses (Anzivino et al., 2009; 
Bukowski et al., 1985).  If the presence of more mature or more abundant NK 
cells is not catastrophic to the fetus or neonate, future studies may be directed 
toward mobilizing NK cells to clear viral pathogens in utero and in newborns. 
 
The medullary and splenic microenvironments seem to drive expression of 
Eomes, while the liver appears non-permissive for Eomes induction.  The micro-
environmental signals upstream of Eomes induction, however, remain to be 
 48	  
elucidated. It also remains possible that there may be cell-intrinsic differences 
between neonatal and adult precursors that favor induction of T-bet alone versus 
T-bet-plus-Eomes, respectively.  We observed derepression of Eomes in steady-
state T-bet-deficient NK cells and in NK cells that acutely lost T-bet.  It is possible 
that T-bet directly or indirectly plays a role in repressing expression of Eomes.  
Lowest levels of T-bet appear to be found in NK cells of the bone marrow, which 
may be mechanistically linked to the observation that TRAIL+ NK cells acquire 
Eomes most readily in the bone marrow following adoptive transfer.  Further 
studies will be needed to understand the relationship between T-bet protein and 
Eomes gene regulation.  The nature and location of the hepatic, medullary, and 
splenic niches that foster Eomes– and Eomes+ NK cells will also need to be 
defined.  
 
Eomes is required for expression of Ly49H, a receptor that is essential to 
mediate resistance against MCMV infection (Arase et al., 2002; Lee et al., 2001). 
While Eomes+DX5+ NK cells are likely to be essential for resistance to some 
infections, it remains to be determined whether TRAIL+ NK cells serve unique 
functions in other aspects of host defense.  Apart from their obvious differences 
in Ly49 repertoire, TRAIL+ and DX5+ NK cells express some similar but some 
dissimilar effector components. Future studies will be directed to determining 
whether TRAIL+ and DX5+ NK cells kill targets in the same manner, whether both 
subsets are capable of memory responses, and whether effector/memory 
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functions are dependent on T-bet, Eomes, or both (Cooper et al., 2009; Paust et 
al., 2010; Sun et al., 2009). 
 
The transcription factors Eomes and T-bet are highly homologous, and they have 
both redundant and non-redundant roles in CD8+ T cell differentiation and 
function (Banerjee et al., 2010; Gordon et al., 2011; Intlekofer et al., 2005; 2007; 
2008; Kinjyo et al., 2010; Pearce et al., 2003; Weinreich et al., 2010).  Their 
overlapping and non-overlapping target genes have not yet been completely 
defined.  The present study reveals that these two factors are molecular 
determinants that control transit through unique NK cell maturational 
checkpoints.  Understanding how expression of T-bet and Eomes is regulated 
and how they, in turn, regulate distinct target genes should offer new avenues to 
customize CD8+ T and NK cellular therapy against infection and cancer. 
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EXPERIMENTAL PROCEDURES 
T-bet- and Eomes-deficient mice 
Mice were housed in specific pathogen-free conditions and used in accordance 
with Institutional Animal Care and Use Guidelines of the University of 
Pennsylvania.  EomesFlox/Flox mice and Tbx21-/- (T-bet KO) mice were generated 
as previously described (Intlekofer et al., 2005; 2008).  EomesFlox/Flox mice were 
mated with Vav1-Cre+ mice (Stadtfeld, 2004) to obtain EomesFlox/Flox, Vav-Cre+ 
(Eomes cKO) mice. Eomes cKO mice were bred with T-bet KO mice to obtain 
EomesFlox/Flox,Tbx21-/-, Vav-Cre+ (DKO) mice.  All strains were backcrossed to 
C57BL/6 for >10 generations.  For all experiments, mice were sex-matched and 
used between 4-16wks of age. 
 
Flow Cytometry 
Liver lymphocytes were obtained by mechanical dissociation of the liver and 
passage through a 70-micron strainer.  The liver was resuspended in 40% 
Percoll and underlaid with 60% Percoll (GE Healthcare).  Lymphocytes were 
isolated at the interphase following centrifugation. Hepatic and other lymphocytes 
were stained with LIVE/DEAD fixable dead cell stain kit (Invitrogen), prior to 
staining with fluorochrome-conjugated antibodies.  Cells were analyzed on an 
LSR II coupled to FACSDiva software (BD Biosciences) and data were analyzed 
with FlowJo software (Treestar, Inc.).  Directly-conjugated monoclonal antibodies 
against the following molecules were purchased from BD Biosciences (BD), 
Biolegend (BL), eBioscience (eBio), Invitrogen (INV) or Santa Cruz 
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Biotechnology (SCBT) and used in our studies (manufacturer and clone indicated 
in parentheses): CD3e allophycocyanin (APC)-Cy7 (BD, 145-2C11); CD4 Pacific 
Blue and phycoerythrin (PE)-Cy5 (BL and BD, RM4-5); CD8 Pacific Blue (BL, 53-
6.7); CD11b PE-Cy5 (Mac-1, BL, M1/70); CD19 APC-Cy7 (BD, 1D3); CD27 PE-
Cy7 (eBio, LG.7F9); CD45.1 Alexa Fluor 700 and fluorescein isothiocyanate 
(FITC) (BL and BD, A20); CD45.2 Alexa Fluor 700, FITC, and Pacific Blue (BL 
and BD, 104); -CD49b eFluor 450 and PE-Cy7 (eBio, DX5); CD51 PE (Integrin 
av, eBio, RMV-7); CD107a Alexa Fluor 488 (LAMP-1, eBio, eBio1D4B); CD122 
biotin, eFluor 450, and PE (BD and eBio, TM-b1); c-kit FITC (BD, 2B8); CXCR3 
peridinin chlorophyll protein (PerCP)-Cy5.5 (eBio, CXCR3-173); Eomes Alexa 
Fluor 647 and PE (eBio, dan11mag); Granzyme B PE-Texas Red (INV, GB11); 
IFN-γ PE-Cy7 (BD, XMG1.2); Ly49A PE and V450 (BD, A1); Ly49C/I PE (BD, 
5E6); Ly49D APC and FITC (eBio and BD, eBio4E5 and 4E5); Ly49G2 APC, 
FITC, and PerCP-eFluor 710 (BD and eBio, 4D11 and eBio4D11); Ly49H APC 
and biotin (eBio, 3D10); Ly6C/Ly6G APC-Cy7 (Gr-1, BD, RB6-8C5); NK1.1 Alexa 
Fluor 700 and PerCP-Cy5.5 (BD, PK136); NKG2A PE (eBio, 16a11); NKp46 
Alexa Fluor 700, eFluor 450, PerCP-eFluor 710 (BD and eBio, 29A1.4); Sca-1 
PE-Cy7 (Ly6A/E, BD, D7); T-bet Alexa Fluor 488 and Alexa Fluor 660 (SCBT 
and eBio, 4B10 and eBio 4B10); Ter119 APC-eFluor 780 (eBio, TER119); TNF-α 
APC (BD, MP6-XT22); and TRAIL PE and biotin (eBio, N2B2).  Binding of biotin-
conjugated antibodies was detected by secondary labeling with streptavidin APC, 
eFluor 710, PE, and PE-Texas Red (BD and eBio).  CXCL16-Fc (Matloubian et 
al., 2000) was generously provided by Mehrdad Matloubian.  CXCL16-Fc was 
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detected by a biotin-conjugated, anti-human Fc antibody (Jackson 
Immunoresearch). 
 
Mixed bone marrow chimeras 
Wild-type (CD45.1+) plus Eomes cKO (CD45.2+) or wild-type (CD45.1+) plus T-
bet KO (CD45.2+) FACS-purified hematopoietic progenitors (Lineage–c-kithighSca-
1high) were used as donor cells. 1 x 103 donor cells were injected intravenously 
into lethally-irradiated (900 rads) Gamma-common, Rag double KO recipients 
(Cao et al., 1995; Shinkai et al., 1992).  Organs of recipients were analyzed 
between 6 and 10 weeks post transplant.  Similar results were observed by 
transplanting 1 x 107 unsorted donor bone marrow cells into sublethally-irradiated 
(400 rads) recipients. 
 
Functional assays 
To purge preformed granules and cytokines, stimulation with 5 ng/mL PMA and 
50 ng/mL Ionomycin was performed for 2 hours in the absence of Brefeldin-A 
and monensin.  To analyze CD107a staining, bulk hepatic lymphocytes were 
stimulated for 2 additional hours with 5 ng/mL PMA and 50 ng/mL Ionomycin, in 
the presence of Brefeldin-A (Golgiplug, BD, 1:1000), monensin (Golgistop, BD, 
1:1000), and anti-CD107a.  To analyze cytokine production, bulk hepatic 
lymphocytes were stimulated for 2 additional hours with 5 ng/mL PMA and 50 
ng/mL Ionomycin, in the presence of Brefeldin-A (Golgiplug, BD, 1:1000) and 
monensin (Golgistop, BD, 1:1000). 
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Adoptive transfer studies 
Splenic and hepatic lymphocytes were isolated and depleted of T, B, 
granulocyte, and erythroid lineages with anti-CD4, -CD5, -CD8, -CD19, -Gr-1, 
and -Ter119 (Biolegend).  Lineage– cells were stained with anti-CD3e, -CD49b 
(DX5), -NK1.1, -NKp46, and -TRAIL.  TRAIL+ and DX5+ NK cells were sorted on 
a FACSAria II (BD).  Purified TRAIL+ or DX5+ NK donor cells were injected 
intravenously into separate, unirradiated Gamma-common, Rag double KO 
recipients. 
 
Temporal deletion studies 
Splenic (for Eomes deletion experiments) or hepatic (for T-bet deletion 
experiments) lymphocytes were isolated and depleted of T, B, granulocyte, and 
erythroid lineages.  Lineage– cells were stained with anti-CD3e, -CD122, -NK1.1, 
and -NKp46.  NK cells were sorted on a FACSAria II and washed thoroughly in 
serum free medium prior to addition of TAT-Cre (50mg/mL) or medium alone 
(sham).  NK cells were then incubated for 45 minutes at 37 C.  The reaction was 
quenched by adding media containing 20% FBS, followed by thorough washing.  
Treated or sham-treated donor cells were injected intravenously into separate, 






Splenic and hepatic lymphocytes were isolated and depleted of T, B, 
granulocyte, and erythroid lineages.  Lineage– cells were stained with anti-CD3e, 
-CD49b (DX5), -NK1.1, -NKp46, and -TRAIL, and TRAIL+ and DX5+ NK cells 
were sorted on a FACSAria II.  RNA was isolated with the miRNeasy kit 
(Qiagen), and cDNA was synthesized with the SuperScript VILO cDNA synthesis 
kit (Invitrogen).  Q-PCR reactions were carried out with a TaqMan 7900HT 
machine and TaqMan gene expression assays (Applied Biosystems).  Relative 
amplification values were calculated by normalizing to amplification of 
hypoxanthine guanine phosphoribosyl transferase (HPRT). 
 
Statistical analysis 
Statistics were calculated with Prism software (GraphPad Software).  To test for 
significant differences in the number of NK cells between 2 groups of adult mice, 
a Student’s t test with a two-tailed P value was performed.  Differences in 
numbers of NK precursors among the 4 genotypes were analyzed with a one-
way ANOVA with a Tukey’s post-comparison test.  Numbers of neonatal NK cells 
among aged-matched wild-type and T-bet KO mice were analyzed with a paired t 





In this thesis work, I found that the highly homologous T-box transcription factors 
T-bet and Eomes are essential for progression of developing NK cells past 
successive checkpoints of maturation.  NKPs give rise to NK antigen-expressing, 
TRAIL+ NK cells (Figure 3.1).  These immature-phenotype NK cells depend on 
T-bet for developmental stability.  TRAIL+ NK cells appear to persist preferentially 
in the liver, existing as a more mercurial intermediate of maturation in the bone 
marrow.  Eomes-dependent mature-phenotype, or DX5+, NK cells arise from 
TRAIL+ NK cells in a postnatal fashion, in the setting of medullary hematopoiesis 
(Figure 3.1).  Future studies will address which signals induce expression of T-
bet and Eomes.  Also of interest are the direct gene targets regulated by T-bet 
and Eomes, in addition to possible interactions among T-bet, Eomes, and a host 
of other transcription factors that appear to regulate maturation of NK cells. 
 
Differentiation of NK cells from lymphoid progenitors 
Hematopoietic stem cells give rise to hematopoietic progenitors that 
progressively differentiate and, in so doing, progressively lose the potential to 
generate different blood lineages.  Having lost erythrocytic and megakaryocytic 
potential along with the ability to self renew, lymphoid-primed multipotent 
progenitors (LMPPs) are thought to be the most primitive committed ancestor of 


































Figure 3.1.  Model of NK cell maturation 
Natural killer precursors (NKP) give rise to phenotypically immature, TRAIL+ NK cells, dependent 
on T-bet for developmental stability.  In turn, TRAIL+ NK cells give rise to phenotypically mature, 
DX5+ NK cells, dependent on Eomes for development and maintenance.  1Approximately 5-10% 
of Eomes– NK cells stain dimly with DX5.  2Approximately 10% of Eomes– NK cells exhibit a 
CD11bhighKLRG1high phenotype.  3Terminal maturation of Eomes+DX5+ NK cells to the 
CD27lowCD11bhighKLRG1highCD43high state is dependent on T-bet. 
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E-protein E2A for stability (Dias et al., 2008), though NK cells develop in normal 
numbers in the absence of E2A (Boos et al., 2007).  Borne from LMPPs, CLPs 
are further restricted to lymphoid lineages (Kondo et al., 1997), but mice 
supposedly deficient in CLPs do not seem to exhibit a deficiency of NK cells (He 
and Malek, 1996; Waskow and Rodewald, 2002). 
 
Nevertheless, adoptive transfer of CLPs in vivo yielded a stable, donor-derived 
NK cell population (Kondo et al., 1997).  Perhaps the best evidence in favor of 
NK cells deriving from CLPs comes from studies in Id2-deficient mice.  In the 
absence of Id2, the development of both NK cells and LTis is severely impaired 
(Boos et al., 2007; Yokota et al., 1999).  Without E2A, B cell development is 
disrupted (Bain et al., 1994; Sun et al., 1991; Zhuang et al., 1994).  When Id2–/– 
mice were bred to homozygosity with E2A–/– mice, development of DX5+ NK cells 
was partially rescued in the bone marrow (Boos et al., 2007).  Of note, however, 
Id2-deficient splenic and peripheral blood NK cells did not increase in number 
after E2A deletion, and DX5+ NK cells in the bone marrow exhibited somewhat 
reduced expression of CD11b.  Deletion of E2A also rescued development of 
LTis (Boos et al., 2007).  These data suggest that Id2 may be a critical regulator 
of commitment of CLPs to innate lymphoid lineages.  Thus, in the absence of Id2, 
unchecked E protein activity in the CLP may drive B cell development at the 
expense of NK cell development.  Upregulated highly at the NKP stage and 
maintained in mNK cells, Id2 seems to be induced as progenitors definitively 
commit to the NK lineage (Boos et al., 2007).  Id3 gene expression also 
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increases from the CLP stage to the NKP stage.  Unlike Id2, Id3 is 
downregulated as immature-phenotype NK cells arise from NKPs.  Levels of Id3 
mRNA are increased in Id2-deficient NKPs cells, which suggests that Id3 may 
partially compensate for Id2 in repressing E proteins and permitting some 
commitment to the NK lineage (Boos et al., 2007).  Complete characterization of 
Id3–/– mice has yet to be performed to assess the requirement for Id3 in 
development and maturation of NK cells.  It has been observed, however, that 
overexpression of Id3 drives NK lineage commitment at the expense of T cell 
commitment in human hematopoietic progenitors grown in fetal thymic organ 
culture (Heemskerk et al., 1997).  A mouse doubly deficient in Id2 and Id3 would 
reveal whether Id2 and Id3 function redundantly at the CLP stage to specify 
differentiation to innate lymphocyte lineages. 
 
TOX also may support the activity of Id2, as both TOX and Id2 are essential to 
specify innate lymphoid lineages (Aliahmad et al., 2010; Boos et al., 2007).  
Additionally, Id2 mRNA in NK cells is relatively decreased in the absence of TOX, 
suggesting that TOX may reinforce expression of Id2 (Aliahmad et al., 2010).  
Consistent with this idea, forced expression of Id2 in TOX-deficient hematopoietic 
progenitors poorly rescued development of NK cells in vitro.  Whether TOX 
directly induces Id2 remains to be investigated.  If TOX maintains expression of 
Id2 and mediates NK lineage commitment downstream of Id2, TOX 




As forced expression of Id2 rescues the defect in NK cell development in E4BP4-
deficient mice, it has been suggested that Id2 necessarily acts downstream of 
E4BP4 (Gascoyne et al., 2009).  Consistent with this hypothesis, overexpression 
of E4BP4 in hematopoietic progenitors resulted in modest induction of Id2.  
However, the assertion that E4BP4 acts as an inducer of Id2 is not consistent 
with the kinetics with which these transcription factors are expressed during NK 
cell differentiation.  Expression of Id2 increases as CLPs transit to the NKP 
stage, whereas induction of E4BP4 is first appreciated in immature-phenotype 
NK cells (Gascoyne et al., 2009).  In addition, the rescue was performed in vitro 
and did not allow for further characterization of Id2-rescued E4BP4-deficient NK 
cells, which may inform to what degree NK maturation was rescued.    An 
alternative explanation for the rescue of NK cell development by Id2 in the 
absence of E4BP4 may be that E4BP4 maintains expression of Id2, among 
others, such as TOX.  Thus, E4BP4-deficient NKPs would be predicted to 
express Id2 and TOX at wild-type levels.  And as TOX appears to act 
downstream of Id2, E4BP4-deficient progenitors transduced with a TOX-
expressing construct would be expected to regain the ability to generate NK cells 
from NKPs. 
 
T-bet and Eomes in a network of factors regulating maturation of NK cells 
Our data suggest that neither T-bet nor Eomes is required to specify NK fate 
from CLPs, as the number of Lin–NK1.1–CD122+ cells in the bone marrow do not 
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differ among wild-type, T-bet KO, Eomes cKO, and DKO mice.  However, T-bet 
or Eomes is essential for stable progression past the NKP.  Thus, the NK cell 
phenotype observed in the DKO animals closely phenocopies that seen in the 
E4BP4-deficient mouse.  T-bet and E4BP4 are induced at the same point in the 
maturation of NK cells, but it remains to be investigated whether E4BP4 and T-
bet interact on some level.  Unlike single deficiency of T-bet, deficiency of E4BP4 
altogether blocks differentiation of any NK cells from NKPs.  This suggests that 
E4BP4 may coordinate a network of genes, such as Tbx21, that promotes 
maturation of NKPs to the TRAIL+ stage and maintenance of TRAIL+ NK cells.  
Given the near-complete absence of NK cells in E4bp4–/– mice, Tbx21 cannot be 
the only target of E4BP4 activity.  Perhaps E4BP4 also regulates expression of 
Eomes. 
 
To test the hypothesis that E4BP4 acts upstream of T-bet and Eomes, we can 
attempt to rescue NK development of E4BP4-deficient hematopoietic progenitors 
in vitro and in vivo with retroviral constructs expressing T-bet or Eomes.  
Alternatively, we can attempt to rescue the NK cell compartment in DKO mice 
with forced expression of E4BP4.  E4BP4 overexpression studies may reveal a 
role for E4BP4 in directly or indirectly inducing expression of T-bet and Eomes.  
To test whether E4BP4 directly binds the Tbx21 or the Eomes locus, chromatin 
immunoprecipitation (ChIP) would need to be performed.  A mouse harboring 
floxed alleles of E4bp4 has not been reported but would prove useful in 
interrogating several aspects of our proposed model.  Temporal deletion of 
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E4BP4 in mature NK cells would allow for gene profiling of the newly E4BP4-
deficient cells.  Of interest would be mRNA levels of Id2, Tox, Tbx21, and Eomes 
in NK cells that lost expression of E4BP4 relative to cells that maintained 
expression of E4BP4. 
 
Another candidate protein that may regulate T-bet is Id2.  Similar to published 
results (Boos et al., 2007; Yokota et al., 1999), our own preliminary 
characterization of Id2-deficient mice revealed a severely diminished NK cell 
compartment in all organs (S.M.G. and S.L.R., in preparation).  We also 
appreciated a reduction in the level of T-bet protein by flow cytometric analysis.  
Expression of Eomes protein in the few remaining NK cells, however, was 
unaltered (S.M.G. and S.L.R., in preparation).  These data are consistent with a 
role for Id2 in directly or indirectly promoting expression of T-bet.  Given that loss 
of Id2 results in the development of many fewer NK cells than does loss of T-bet, 
Id2 may coordinate expression of an array of other transcription factors required 
for differentiation, proliferation, or survival of NK cells. 
 
GATA-3 also may positively regulate expression of T-bet, as GATA-3 deficient 
NK cells exhibited a reduction in T-bet mRNA (Samson et al., 2003).  The size 
and phenotype of the NK cell compartment in GATA-3-deficient animals does not 
suggest an early role for GATA-3 in maturation of NK cells.  However, E4BP4-
deficient hematopoietic progenitors exhibited substantially reduced levels of 
GATA-3 mRNA relative to wild-type progenitors (Gascoyne et al., 2009).  Further, 
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forced expression of E4BP4 resulted in a moderate induction of GATA-3 mRNA.  
Similar to deficiency of T-bet, deficiency of GATA-3 results in NK cells that 
appear somewhat arrested in development and home poorly to the liver (Samson 
et al., 2003).  Unlike T-bet-deficient NK cells, however, GATA-3-deficient NK 
cells display an altered repertoire of Ly49 receptors and produce limited IFN-γ 
after stimulation.  These data are consistent with a role for GATA-3 in directly or 
indirectly inducing maximal expression of T-bet, though GATA-3 likely regulates 
other factors, as well.  No data to date support a direct interaction between 
GATA-3 and the Tbx21 locus.  One report provided evidence for a direct 
interaction between T-bet and GATA-3 proteins in TH1 cells, though this 
interaction involved T-bet inhibiting GATA-3 from binding DNA at target genes 
(Hwang et al., 2005).  In NK cells, in contrast, GATA-3 and T-bet appear to 
cooperate, not only to induce expression of IFN-γ but also to drive terminal 
differentiation of NK cells.  More detailed investigation into the phenotype and 
gene expression profile of GATA-3-deficient NK cells will be required in the 
future.  Floxed alleles of Gata3 have been generated and would greatly aid the 
study of targets of GATA-3 activity.  Of interest, one direct or indirect target of 
GATA-3 appears to be Ly49D (Samson et al., 2003), also an apparent target of 
Eomes.   
 
Regulation of Transcription by Eomes 
Our data suggest that Eomes is required for the induction but not the 








Figure 3.2. Model of the transcriptional network governing NK cell development 
Common lymphoid progenitors (CLP) give rise to T-, B-, and innate lymphoid-lineage cells.  Key 
players in specifying innate lymphoid fate are the Id proteins, known to inhibit T- and B-lineage-
specifying E proteins.  TOX may act with Id proteins to specify innate lymphoid progenitors (ILP) 
and, later, to reinforce Id2 expression early in NK cell development and to effect events 
downstream of Id2.  Also critical for maturation past the NKP is E4BP4, which may be a target 
and a driver of the Id2-TOX axis.  E4BP4 may directly and/or indirectly induce expression of T-bet 
and Eomes, without which NK maturation is also halted at the NKP stage.  T-bet and Ets-1 may 
stabilize the TRAIL+ state by restricting induction of Eomes.  In mature NK cells, however, T-bet 
may act independently and through Blimp-1 to direct terminal maturation of NK cells. 
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do not support a model in which Eomes binds directly to Klra4 (encoding Ly49D) 
and maintains an active presence at the locus to direct transcription.  Eomes may 
bind to Klra4, but it may direct histone-modifying enzymes to the region.  Instead, 
Eomes may induce expression of chromatin modifiers.  Alternatively Eomes may 
not be a direct regulator of histone modifications, but it does appear to be 
upstream of stable changes to chromatin that promote expression of Ly49 genes.  
Such transcription factors as GATA-3 or PU.1, loss of which also is incompatible 
with expression of Ly49D on NK cells (Colucci et al., 2001; Samson et al., 2003), 
may then access the open Klra4 locus. 
 
The hypothesis that Eomes regulates Ly49 expression through epigenetic 
mechanisms derives not only from our data garnered from temporal deletion of 
Eomes in NK cells but also from previous studies suggesting that expression of 
Klra genes is associated with epigenetic modifications (Rouhi et al., 2006; 2007; 
2009).  Understanding the role of Eomes in regulating certain genes within the 
Ly49 locus may be challenging, as Ly49 genes are clustered and regulation of 
the genes is complex.  For instance, two separate but overlapping promoters, 
known as Pro1 and Pro2, may coordinate expression of Klra genes encoding 
inhibitory Ly49 receptors (Saleh et al., 2004).  Klra genes encoding the activating 
Ly49 family members Ly49D and Ly49H were found to have only one active 
promoter (Pro2), though these data do not rule out regulation of these loci by 
other promoter elements.  Further support for unique regulation of Ly49D and 
Ly49H comes from a report detailing that these two activating Ly49 receptors 
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deviate from the “product rule” adhered to by inhibitory Ly49 receptors (Smith et 
al., 2000).  The product rule argues that expression of Ly49 receptors on NK 
cells is stochastic (Raulet et al., 1997).  Specifically, the rule states that the 
frequency of NK cells co-expressing two or more Ly49 receptors (Ly49A and 
Ly49G2, for example) can be predicted by the product of the frequencies of 
Ly49A single-positive and Ly49G2 single-positive cells. 
 
To test whether chromatin-modifying proteins or Ly49 receptors are direct targets 
of Eomes, ChIP for native Eomes currently is being developed in our lab.  Il2rb 
has been established as a direct target of Eomes in T cells overexpressing a 
FLAG-tagged version of Eomes (Intlekofer et al., 2005).  Consistent with those 
data, we find that expression of CD122 protein increases in NK cells with 
increasing amounts of Eomes protein (TRAIL+ NK < DX5+ NK < T-bet KO NK) 
(S.M.G. and S.L.R., in preparation).  Thus, Il2rb will serve as our positive control 
as we develop ChIP for Eomes in NK cells.  In time, we aim to perform ChIP-seq 
to obtain a more comprehensive array of genes to which Eomes may bind in NK 
cells.  Of note, Eomes may not positively regulate all of its targets.  For instance, 
our data collected from temporally deleting Eomes suggest that the genes 
encoding TRAIL, CXCR6, and integrin αv are negatively regulated by Eomes in 
NK cells. It remains to be determined, however, whether Eomes directly or 
indirectly represses these genes associated with immature-phenotype NK cells. 
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The Eomes protein contains relatively large N and C termini that surround the T-
box domain (Pearce et al., 2003).  No function has been ascribed to any region 
of Eomes beyond the DNA-binding domain.  The possibility that the N terminus, 
C terminus, or both termini may interact with histone-modifying proteins is thus 
intriguing.  Of general interest is to identify factors that bind and work with Eomes 
at genetic loci.  Aside from chromatin modifiers, candidates would include 
Smad2/3.  Recently shown by ChIP-seq in human HSCs cultured in vitro, Eomes 
and Smad2/3 were found to bind many of the same genes at the same sites in 
promoters (Teo et al., 2011).  Successive ChIP, or ChIP for Smad2/3, 
immediately followed by ChIP for Eomes, revealed that Eomes can be found 
complexed with Smad2/3 at target genes, including Eomes itself. 
 
Regulation of Eomes by NK cell-intrinsic factors 
Prior studies in Xenopus laevis embryos reported that signals by TGF-β 
superfamily members result in induction of Eomes (Ryan et al., 2000).  And TGF-
β signaling the embryo is communicated via phosphorylation of Smads, 
specifically Smad2/3 (Graff et al., 1996; Zhang et al., 1996).  Given these data, 
Smad2/3 are obvious candidates to be regulated differentially in TRAIL+ and 
DX5+ NK cells.  Preliminary microarray analysis and preliminary targeted qRT-
PCR did not uncover a difference in the levels of Smad2/3 mRNA between 
TRAIL+ and DX5+ NK cells (S.M.G. and S.L.R., in preparation).  However, these 
data do not nullify the hypothesis that Smad2/3 induces Eomes in DX5+ NK cells.  
As Smads are activated by post-translational modification, a more appropriate 
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approach to test this hypothesis would be by western blot for phosphorylated 
Smad2/3 in TRAIL+ and DX5+ NK cells.  As NK cells are relatively rare in wild-
type mice, this experiment is challenging technically.  With increased numbers of 
NK cells, RAG-deficient mice may be used to isolate cells, and western blot 
analysis on populations as small as 25,000 cells recently has been reported in 
the literature (Nakada et al., 2010). 
 
While Smad2/3 may activate transcription of Eomes, T-bet and Ets-1 may 
repress Eomes.  T-bet-deficient NK cells expressed markedly increased amounts 
of Eomes protein in the steady state.  Also, NK cells in which T-bet was 
temporally deleted exhibited an acute increase in levels of Eomes protein.  
Preliminary analysis of Ets-1-deficient NK cells suggests that Ets-1 also plays a 
role in restricting expression of Eomes (S.M.G. and S.L.R., in preparation).  
Thus, Ets1–/– and Tbx21–/– NK cells appear to exhibit a similar phenotype, though 
the two mutant mice remain to be compared in the same experiment.  
Cooperation of T-bet and Ets-1 has been described previously in the literature. 
Each factor plays a role in production of IFN-γ by CD4 T cells, and it was found 
that T-bet and Ets-1 both bind at the Ifng locus but do not appear to interact 
directly (Grenningloh, 2005).  Whether T-bet and Ets-1 also cooperate to repress 
Eomes has yet to be tested by ChIP and overexpression studies. 
 
Overexpression studies with T-bet may be difficult to interpret, based on the 
apparent dual-nature of T-bet activity in developing NK cells.  On one hand, T-bet 
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is required to stabilize TRAIL+ NK cells, intermediates of NK cell maturation.  On 
the other hand, our data support a cell-intrinsic requirement for T-bet in the 
terminal maturation of NK cells.  In fact, T-bet may work in tandem with Blimp-1 
to specify terminal differentiation of NK cells.  It has been reported that 
expression of Prdm1 (encoding Blimp-1) is reduced in NK cells lacking T-bet 
(Kallies et al., 2011).  These data are consistent with our preliminary microarray 
analysis and targeted qRT-PCR findings that levels of Blimp-1 mRNA increases 
as NK cells transit closer to maturity. 
 
It seems unlikely that T-bet regulates the same set of genes to stabilize TRAIL+ 
NK cells and to generate DX5+CD27lowCD11bhighCD43+ NK cells.  Instead, these 
data suggest that T-bet may associate with different partners in immature and 
mature NK cells to coordinate expression of different sets of target genes.  As T-
bet is known to be post-translationally modified (Hwang et al., 2005), these 
phosphorylation events may dictate with which transcription complexes T-bet 
associates.  For example, similar to its role in TH1 cells, phospho-T-bet may 
inhibit a Smad2/3 complex from binding to the Eomes gene in TRAIL+ NK cells.  
Alternatively, differential phosphorylation of T-bet may enhance or otherwise alter 
its ability to bind T-box sites and to regulate transcription of target genes directly.  
Immunoprecipitation of T-bet, followed by western blotting for phosphorylated 
tyrosine or serine/threonine residues, may reveal that T-bet is differentially 
modified in TRAIL+ NK cells, versus terminally mature DX5+ NK cells. 
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Regulation of Eomes by NK cell-extrinsic factors 
Expression of Eomes and, thus, maturation of NK cells seems tightly regulated.  
Eomes+ NK cells are not seen in the neonatal liver and are infrequent in the 
neonatal spleen, relative to the adult spleen.  The appearance of Eomes-
expressing DX5+ NK cells correlates with the shift from extramedullary (hepatic) 
hematopoiesis to medullary hematopoiesis after birth.  Even in the adult, the liver 
remains the preferred environment for stable TRAIL+Eomes– NK cells, while the 
bone marrow appears to foster the rapid induction of Eomes and the rapid 
maturation of TRAIL+ NK cells. To test whether the bone marrow environment is 
required to generate DX5+Eomes+ NK cells, we examined the NK cell 
compartment in several different mouse models of osteopetrosis.  Characterized 
by a lack of osteoclast-mediated bone resorption, osteopetrotic mice resulted 
from disruption of the RANK/RANKL pathway, required for differentiation and 
survival of osteoclasts (Hsu et al., 1999; Kong et al., 1999; Lomaga et al., 1999).  
Thus, the marrow cavity fills with bone and hematopoietic progenitors are forced 
to return to their former home in the liver and spleen.  In osteopetrotic mice, we 
observed a return to a neonatal state of NK cell maturation, in which very few 
Eomes+ NK cells were observed in the liver, relative to littermate controls (S.M.G. 
and S.L.R., in preparation).  The ratio of Eomes+ to Eomes– NK cells in the 
spleens of osteopetrotic mice were unchanged, relative to littermate controls.  
These data support a model in which hepatic hematopoiesis restricts expression 
of Eomes and maturation of NK cells.  In contrast, medullary hematopoiesis and 
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the splenic environment seem to foster induction of Eomes and development of 
DX5+ NK cells. 
 
The precise environmental signals responsible for the induction of Eomes, 
however, remain to be investigated.  One clue we have comes from our adoptive 
transfer studies of purified wild-type TRAIL+ NK cells into Rag 2, gamma-
common double KO recipients.  We found that TRAIL+ NK cells upregulate 
Eomes and convert to DX5+ NK cells efficiently, in the absence of adaptive 
immune lymphocytes.  These data suggest that NK-T and NK-B interactions are 
dispensable for induction of Eomes and maturation of TRAIL+ NK cells.  Perhaps 
bone marrow stromal cells instruct medullary NK cells to express Eomes.  
Alternatively, distinct dendritic cells or other myeloid cells in the bone marrow 
(and not present in the liver) provide signals that result in Eomes transcription. 
 
The lab is currently breeding a particularly useful tool to understand the upstream 
events occurring in NK cells signaled to induce expression of Eomes.  A reporter 
mouse was generated in which one allele of Eomes is replaced by the coding 
sequence for GFP (Arnold et al., 2009).  We have since bred this mouse to mice 
harboring floxed alleles of Eomes and expressing Cre recombinase under Vav1 
regulatory elements to yield pups with the genotype EomesGFP/Flox, Vav-Cre+.  
These mice cannot express Eomes protein to become DX5+ NK cells, but our 
preliminary studies indicate that a percentage of TRAIL+ NK cells in bone 
marrow, spleen, and liver express GFP (S.M.G. and S.L.R., in preparation).  In 
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other words, we can now identify NK cells being actively signaled to transcribe 
Eomes.  Comparative genome-wide expression profiling of TRAIL+GFP+ NK cells 
and TRAIL+GFP– NK cells may reveal induction of signaling pathways that 
culminate in expression of Eomes. 
 
Preliminary microarray analysis revealed that wild-type TRAIL+ NK cells and 
Eomes cKO TRAIL+ NK cells express elevated levels of several cytokine 
receptors that pair with the gamma-common chain, relative to DX5+ NK cells 
(S.M.G. and S.L.R., in preparation).  The differentially regulated genes encode 
receptors for IL-2, IL-4, IL-7, and IL-21.  Perhaps those cytokines, singly or in 
various combinations, can promote the maintenance of TRAIL+ NK cells.  
Alternatively, recent work in innate-like lymphocytes suggests that IL-4 can 
induce expression of Eomes (Weinreich et al., 2010).  Consistent with those 
data, NK cells that exist in an IL-4-biased environment, such as a BALB/c mouse, 
appear to exhibit a bias toward Eomes-expressing NK cells, relative to C57BL/6 
controls (S.M.G. and S.L.R., in preparation).  Additional work remains, however, 
using mice deficient in IL-4/IL-4R to understand the requirement for this cytokine 
in inducing maturation of TRAIL+ NK cells.  Studies of NK cell differentiation in 
vitro in the presence of various combinations of IL-2, IL-4, IL-7, and IL-21 may 
further our understanding of the relative contributions of those cytokines to 
maturation of NK cells.  Previous work may also inform our future studies in this 
area, as administration of IL-21 to NK cells in vitro and in vivo resulted in 
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induction of effector genes and of surface markers, such as KLRG-1, that are 
associated with later stages of maturation (Brady et al., 2004). 
 
T-bet and Eomes in maturation of human NK cells 
A clear future direction of this work would be to extend our findings in the mouse 
and investigate the roles of T-bet and Eomes in hNK cells.  Like development of 
murine NK cells, hNK cells are thought to develop in a stepwise fashion, with 
each step characterized by a distinct profile of surface proteins (Freud and 
Caligiuri, 2006).  Intermediates of hNK cell maturation are enriched highly in 
secondary lymphoid tissue, such as lymph nodes and tonsils.  Minimal 
characterization of the NK compartment in the liver has been completed to date.  
We have performed preliminary analyses of T-bet and Eomes protein expression 
in NK cells of adult blood, umbilical cord blood, and fetal liver.  We found that 
essentially all CD56+CD3– cells express T-bet and Eomes, though the 
CD56lowCD16high subset appears to express elevated levels of T-bet (S.M.G. and 
S.L.R., in preparation), consistent with the terminally mature status of these cells 
(Freud and Caligiuri, 2006).  In the neonatal mouse, we have shown that the vast 
majority of NK cells are TRAIL+Eomes–, so we hypothesized that human fetal 
liver would be devoid of Eomes+ hNK cells.  Contrary to our hypothesis, 
preliminary characterization of hNK cells in the fetal liver indicated that the 
majority of hNK cells express Eomes (S.M.G. and S.L.R., in preparation).  
Consistent with our results in the mouse, however, we also identified a 
population of CD56+ NK cells that appeared to lack expression of Eomes protein 
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but appeared to exhibit expression of TRAIL.  These TRAIL+ hNK cells also did 
not express T-bet protein, suggesting that developmental regulation of T-bet and 
Eomes may differ between mouse and man (S.M.G. and S.L.R., in preparation). 
 
While of interest, these data are preliminary and limited with respect to identifying 
CD56– intermediates of development that may precede induction of T-bet and 
Eomes.  In order to more clearly understand at which stage of maturation T-bet 
and Eomes are induced, human CD34+ hematopoietic progenitors can be 
isolated and instructed to differentiate into hNK cells on a murine fetal liver-
derived cell line, EL08.1D2 (Grzywacz et al., 2006; McCullar et al., 2008).  
Maturing NK cells can be harvested from the stromal layer at various time points, 
can be carefully staged by detection of surface proteins, and can be analyzed for 
expression of T-bet and Eomes.  In addition, any links between induction of T-bet 
and Eomes and induction of KIRs or other surface receptors can be investigated. 
 
Perspective 
NK cells have emerged as key players in human immunity to viruses and 
cancers, necessitating a more complete understanding of how NK cells 
differentiate and mature.  Few transcription factors have been identified clearly to 
direct development of NK cells.  Our findings that T-bet and Eomes are essential 
for developing NK cells to progress through successive checkpoints in maturation 
represent a significant advance in the field of NK developmental biology.  Moving 
forward, it will be critical to integrate our findings with prior reports of impaired 
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differentiation or maturation of NK cells in the setting of transcription factor 
deficiencies.  As we uncover the precise ontogeny of NK cells and unravel the 
network of NK cell-intrinsic and -extrinsic factors that regulate development of NK 
cells, we can enhance our potential to harness the capabilities of NK cells in the 
setting of human disease.  
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